[{"text": "PREMIUM Evolus Reports Q4 Preliminary Net Revenue; Shares Rise Pre-Bell MT Newswires Tue, Jan 21, 2025, 5:23 PM In This Article: EOLS -7.09% Evolus (EOLS) said Tuesday it expects Q4 net revenue of $79 million, up 30% from a year earlier. PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "EOLS", "date": "2025-01-21T17:23:48", "sentiment": {"score": 0.3642593612894416, "confidence": 0.37398040294647217, "probabilities": {"positive": 0.37398040294647217, "negative": 0.009721041657030582, "neutral": 0.6162986159324646}}, "embedding": [-0.03892642632126808, -0.004486067220568657, -0.06831661611795425, 0.04666317626833916, -0.05596578121185303, 0.05244491994380951, 0.03401174768805504, 0.05040161311626434, 0.13252069056034088, 0.02947820909321308, 0.09381027519702911, 0.08207925409078598, 0.0004784253833349794, 0.06877125054597855, 0.027894504368305206, 0.006806231569498777, 0.1170472726225853, -0.20148512721061707, 0.011589804664254189, -0.0773564949631691, -0.05635077878832817, -0.1644768863916397, -0.026896556839346886, -0.14656224846839905, 0.24568438529968262, -0.07533266395330429, -0.17296102643013, 0.07271937280893326, 0.08869864791631699, -0.13295790553092957, 0.059269506484270096, -0.018424920737743378, 0.09879997372627258, -0.12536920607089996, 0.02533446066081524, -0.12486045807600021, -0.042059142142534256, -0.06866110861301422, -0.09046494215726852, 0.04245588928461075, 0.09103903919458389, -0.09175969660282135, -0.32294413447380066, -0.003936314024031162, -0.08449987322092056, -0.017089851200580597, 0.0446716770529747, 0.16662734746932983, 0.0942968875169754, -0.020165594294667244, 0.05492808669805527, -0.0903751403093338, 0.1393732875585556, -0.05283919349312782, -0.08078376948833466, -0.02025919407606125, -0.1977652609348297, -0.12846936285495758, 0.04515666142106056, -0.000656446791253984, 0.04023905098438263, -0.02642437443137169, -0.1454119086265564, 0.196772962808609, -0.08087479323148727, 0.118839330971241, 0.12020982056856155, 0.1908380687236786, -0.25858885049819946, -0.11502048373222351, -0.003365773241966963, 0.025915728881955147, -0.05155247822403908, 0.0030545343179255724, 0.015035849995911121, 0.2209172546863556, 0.23186178505420685, 0.02398970164358616, -0.011483494192361832, -0.1367642730474472, -0.005467593669891357, -0.04093976691365242, -0.10917890816926956, -0.12076997756958008, 0.01019600685685873, 0.10359445959329605, 0.04424949362874031, -0.09548620879650116, 0.018993426114320755, 0.00014297105371952057, 0.15174150466918945, -0.131429985165596, -0.002821853617206216, -0.007436695508658886, 0.053103841841220856, 0.1346573382616043, -0.1266082376241684, -0.2888225317001343, 0.04756614938378334, 0.06362943351268768, 0.06126539409160614, 0.21006816625595093, -0.02047073096036911, -0.025464054197072983, -0.019154954701662064, -0.04282159358263016, 0.09323620796203613, 0.251164048910141, 0.018756667152047157, 0.049542974680662155, -0.06770385801792145, -0.03664051741361618, -0.031758032739162445, -0.1677234172821045, -0.03752319514751434, 0.19814206659793854, -0.10705529898405075, 0.11699320375919342, 0.10770761221647263, -0.09675290435552597, 0.09856127947568893, 0.10813304781913757, -0.14260591566562653, 0.07764524966478348, 0.015838803723454475, 0.05279993638396263, -0.038430918008089066, 1.3776016495997728e-32, 0.013668463565409184, 0.13189834356307983, 0.10182954370975494, -0.17428894340991974, 0.09070123732089996, 0.07283828407526016, 0.15783673524856567, -0.01917521469295025, -0.17786692082881927, -0.011557426303625107, -0.18417438864707947, 0.15860606729984283, 0.02754429541528225, 0.03625135496258736, -0.009298579767346382, -0.15274858474731445, -0.14454688131809235, 0.03806910291314125, 0.1499464064836502, 0.01314376201480627, 0.028943276032805443, -0.15285934507846832, 0.06124608591198921, 0.1282639354467392, -0.05932913348078728, 0.22081346809864044, 0.1154380813241005, -0.03544849902391434, 0.11056242138147354, 0.11877577006816864, -0.1810508370399475, 0.14804090559482574, -0.026167623698711395, -0.17061160504817963, -0.04087444022297859, 0.17284999787807465, -0.012728756293654442, -0.040232013911008835, 0.07995665818452835, -0.059390366077423096, -0.03124593384563923, -0.04437929764389992, -0.1022142693400383, -0.17032717168331146, -0.16961784660816193, -0.05628252401947975, 0.06517868489027023, -0.13339805603027344, 0.10532930493354797, -0.09214949607849121, -0.06047813594341278, 0.039991993457078934, -0.1693267971277237, -0.01356167159974575, 0.0055449106730520725, 0.04677612707018852, -0.013621928170323372, 0.07805725932121277, 0.053396038711071014, -0.05136715620756149, 0.08678735047578812, 0.1740991622209549, -0.021773630753159523, 0.0018473973032087088, -0.1337020844221115, 0.26022911071777344, -0.01403640303760767, -0.17893806099891663, -0.1497018188238144, 0.14086253941059113, 0.1891539841890335, -0.10988949239253998, 0.0643073171377182, -0.016467180103063583, 0.09674163907766342, 0.05006478354334831, -0.12326326221227646, -0.0682937428355217, 0.287672221660614, 0.15242426097393036, -0.07303983718156815, 0.03879236802458763, 0.11102242767810822, -0.056002430617809296, 0.22133737802505493, -0.11346456408500671, 0.07599972188472748, 0.0547720231115818, 0.060851097106933594, 0.1448962390422821, 0.09432051330804825, 0.02281327173113823, -0.09555619210004807, 0.19464640319347382, -0.08423220366239548, -1.3362912516288252e-32, -0.12724295258522034, 0.14888881146907806, -0.0732649713754654, 0.02404072694480419, -0.21588729321956635, 0.014883504249155521, -0.05690716952085495, 0.27561721205711365, 0.010198235511779785, 0.14598296582698822, -0.016617346554994583, 0.12342587113380432, -0.10795065015554428, 0.02774069644510746, 0.061188653111457825, -0.010258237831294537, 0.08905425667762756, -0.1918526589870453, 0.0035408446565270424, 0.04056715965270996, -0.11794720590114594, 0.13646723330020905, -0.03290770947933197, 0.2659422755241394, 0.276979923248291, -0.04105721414089203, 0.1626361757516861, 0.122717946767807, -0.057223692536354065, -0.08988062292337418, -0.09412907809019089, -0.19864235818386078, -0.1612640768289566, -0.05456922948360443, -0.07820776104927063, -0.01202244870364666, 0.23731331527233124, 0.05293308570981026, 0.09976451098918915, -0.04832968860864639, 0.1040736585855484, -0.061365365982055664, 0.033109914511442184, -0.043706778436899185, 0.0775434598326683, 0.008776804432272911, -0.043290864676237106, -0.032046616077423096, 0.08946583420038223, 0.024198314175009727, 0.042878542095422745, 0.10795637965202332, 0.02239677496254444, 0.2579660713672638, -0.15415386855602264, 0.0663202553987503, -0.05789637565612793, 0.10947336256504059, -0.11823462694883347, -0.09292270988225937, 0.021659890189766884, 0.10927168279886246, -0.09107878804206848, 0.11172695457935333, 0.049916110932826996, -0.08894532173871994, 0.0813702791929245, -0.07184621691703796, -0.03658654913306236, -0.24764704704284668, 0.04008389636874199, -0.08727671205997467, -0.13487647473812103, -0.3319278657436371, 0.013331878930330276, 0.29178714752197266, -0.08620300143957138, -0.06304200738668442, -0.01185530237853527, -0.08713573962450027, 0.005259322933852673, 0.07757352292537689, 0.024934226647019386, -0.13439513742923737, -0.0857778862118721, -0.09033915400505066, 0.13506466150283813, -0.041284624487161636, -0.011189447715878487, 0.0883718803524971, -0.10449255257844925, -0.04479595646262169, -0.03902234137058258, 0.17068497836589813, 0.15174774825572968, -9.938377587559444e-08, 0.08726437389850616, 0.026524566113948822, 0.06316058337688446, -0.04791059345006943, 0.0697636678814888, -0.1744728684425354, 0.0850103348493576, 0.13494624197483063, -0.04837017133831978, 0.14037179946899414, -0.016753297299146652, -0.0906989797949791, -0.044660720974206924, -0.007239053957164288, -0.01626248098909855, 0.09181153029203415, -0.06874178349971771, -0.005743922665715218, 0.00042700927588157356, -0.14514116942882538, 0.1591637283563614, 0.09545338898897171, 0.1016845852136612, -0.11905504763126373, -0.002843377646058798, -0.09105846285820007, 0.11939983069896698, -0.020138712599873543, 0.04853522777557373, -0.1632862091064453, -0.04132110998034477, 0.037504568696022034, -0.10532744973897934, -0.12616805732250214, -0.07879980653524399, -0.07101460546255112, -0.04837121069431305, -0.028225068002939224, 0.03170064091682434, 0.09792646020650864, -0.06269104778766632, -0.14719587564468384, 0.08846645802259445, -0.03935115411877632, -0.17895449697971344, 0.11248872429132462, -0.35596004128456116, -0.11743758618831635, 0.12863299250602722, -0.23354177176952362, 0.03516576439142227, -0.06305648386478424, 0.0663985013961792, -0.05100276693701744, 0.04598376527428627, -0.1338992714881897, 0.01816946640610695, -0.052137233316898346, -0.024597428739070892, -0.03984050080180168, 0.09170103073120117, -0.27114787697792053, 0.007679053582251072, 0.04761376231908798], "changes": {"1wk": 9.495554377690699}}, {"text": "Evolus (EOLS) Surges 28.3%: Is This an Indication of Further Gains? Zacks Equity Research Wed, Jan 22, 2025, 3:46 PM 2 min read In This Article: EOLS -7.09% OGI -3.33% Evolus, Inc. (EOLS) shares rallied 28.3% in the last trading session to close at $13.48. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 3% loss over the past four weeks. The sharp upsurge in EOLS shares can be attributed to positive market sentiment surrounding the company\u2019s impressive preliminary results and strong growth outlook. Evolus reported a strong preliminary Q4 2024 performance, posting $79 million in sales, a 30% year-over-year increase, and surpassing expectations. Investors are optimistic about the company\u2019s continued growth, as it projects net revenues of $345 million to $355 million in 2025, a 30% to 33% growth from 2024. Additionally, the company\u2019s upcoming product launches, including FDA approvals for Evolysse Form and Evolysse Smooth, have further fueled investor confidence. With these promising developments, Evolus is positioned for continued earnings and revenue growth, driving the stock\u2019s upward momentum. This company is expected to post quarterly earnings of $0.04 per share in its upcoming report, which represents a year-over-year change of +128.6%. Revenues are expected to be $77.2 million, up 26.6% from the year-ago quarter. Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. For Evolus, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on EOLS going forward to see if this recent jump can turn into more strength down the road. The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Evolus is a member of the Zacks Medical - Products industry. One other stock in the same industry, OrganiGram (OGI), finished the last trading session 0.7% lower at $1.54. OGI has returned -1.9% over the past month. OrganiGram's consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0.03. Compared to the company's year-ago EPS, this represents a change of +78.6%. OrganiGram currently boasts a Zacks Rank of #2 (Buy). Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Story Continues Evolus, Inc. (EOLS) : Free Stock Analysis Report Organigram Holdings Inc. (OGI) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "EOLS", "date": "2025-01-22T15:46:00", "sentiment": {"score": 0.9299745690077543, "confidence": 0.9479376077651978, "probabilities": {"positive": 0.9479376077651978, "negative": 0.017963038757443428, "neutral": 0.03409935161471367}}, "embedding": [-0.10995415598154068, -0.0036969061475247145, -0.06824394315481186, -0.007879217155277729, -0.037686172872781754, -0.055977098643779755, -0.045482851564884186, 0.14215272665023804, 0.1794804334640503, 0.039565522223711014, -0.02770623378455639, 0.11511953920125961, -0.02794879861176014, -0.11568082869052887, -0.03892193362116814, -0.023546187207102776, 0.045184310525655746, -0.0635816752910614, -0.11629168689250946, -0.008337941020727158, -0.05565708130598068, -0.14509961009025574, 0.027600353583693504, -0.05042650178074837, 0.11212263256311417, 0.015887215733528137, -0.06048592925071716, 0.07265789806842804, -0.09368245303630829, -0.19274763762950897, -0.004999643191695213, 0.008597448468208313, 0.07644679397344589, -0.10335563868284225, -0.0713658332824707, -0.0805024802684784, 0.004345935769379139, -0.0004276484251022339, 0.053089939057826996, -0.06332316994667053, -0.024460729211568832, -0.049753256142139435, -0.16569627821445465, -0.07164469361305237, -0.1338416337966919, -0.1284666359424591, 0.02427266165614128, 0.06841626018285751, 0.01273990049958229, -0.012636146508157253, -0.12577146291732788, -0.1341134011745453, 0.06587491929531097, -0.06655839085578918, -0.1014285460114479, 0.0585605688393116, -0.11306875944137573, -0.12183127552270889, 0.10992957651615143, 0.023383978754281998, 0.0842338502407074, 0.06992135941982269, -0.015474425628781319, 0.13332417607307434, 0.05983895808458328, -0.0026896712370216846, 0.15297013521194458, 0.007625117897987366, -0.17154929041862488, 0.0812436044216156, 0.10255427658557892, -0.04182637855410576, -0.06291894614696503, -0.03080172650516033, -0.06881169229745865, 0.12785446643829346, 0.13549387454986572, 0.03782007843255997, 0.12261881679296494, -0.10124030709266663, 0.02588038332760334, -0.006492775399237871, -0.08401603251695633, -0.1411886066198349, -0.0680723786354065, 0.0590246319770813, 0.12399418652057648, 0.04676252603530884, 0.09720854461193085, 0.0893426388502121, 0.11303474009037018, -0.1272667944431305, -0.05350199341773987, 0.01143140159547329, 0.1211027055978775, 0.1536129117012024, -0.07307738065719604, -0.1372320055961609, 0.049001775681972504, 0.10226178169250488, 0.08875587582588196, 0.27082815766334534, 0.007949849590659142, -0.06334985792636871, -0.0730520486831665, -0.07917957007884979, 0.09184719622135162, 0.02449009194970131, -0.022618740797042847, 0.04684683680534363, -0.08713548630475998, -0.056667447090148926, -0.15859708189964294, -0.04585499316453934, -0.1018596887588501, 0.07287673652172089, -0.03983864560723305, 0.0950232744216919, 0.09721937775611877, 0.0060959188267588615, 0.19742338359355927, 0.10198797285556793, -0.04898307844996452, 0.0941426083445549, 0.024531308561563492, 0.05008098483085632, -0.10980281978845596, 1.0050847714935036e-32, 0.02960154414176941, 0.02961764484643936, -0.06512743979692459, -0.03585901856422424, -0.021915806457400322, 0.10734700411558151, 0.05093643441796303, 0.03521289676427841, -0.09268920123577118, -0.03905067592859268, -0.2240290343761444, 0.1335832178592682, 0.040370382368564606, -0.03638653829693794, 0.03536178916692734, -0.12361222505569458, -0.053926657885313034, 0.0881962701678276, 0.009479356929659843, -0.018935315310955048, 0.048555999994277954, -0.0775652602314949, 0.0011543454602360725, -0.0017197802662849426, 0.015890654176473618, 0.05159710347652435, -0.030278101563453674, 0.00015815161168575287, -0.12085628509521484, 0.057468757033348083, 0.032556239515542984, 0.023030657321214676, -0.05390603840351105, -0.0829174816608429, -0.04167158156633377, -0.06089063361287117, -0.03560347855091095, -0.06916962563991547, 0.207783043384552, -0.04592902958393097, -0.05753215774893761, 0.11152631044387817, -0.1879795491695404, -0.10473038256168365, -0.09272917360067368, 0.0386330708861351, -0.01282677985727787, -0.03739882633090019, -0.009428530931472778, -0.05718127265572548, -0.0047385795041918755, 0.04855680838227272, -0.03614002466201782, -0.08274778723716736, -0.038507431745529175, 0.0262529905885458, -0.01265732292085886, 0.015805967152118683, 0.08234335482120514, 0.07539435476064682, -0.10440819710493088, 0.33966171741485596, 0.05201109126210213, -0.06427035480737686, -0.16507166624069214, 0.23955968022346497, -0.05898328498005867, 0.006348928436636925, -0.12835107743740082, 0.13466429710388184, 0.034391023218631744, -0.0793655514717102, 0.0789855495095253, -0.10983514785766602, 0.1861172765493393, -0.04688864201307297, -0.021452931687235832, -0.013924026861786842, 0.10534071922302246, 0.03891226649284363, -0.0008964438457041979, -0.053960349410772324, 0.019389072433114052, -0.0048198821023106575, 0.0840454250574112, -0.08126591891050339, -0.11426811665296555, 0.10025215148925781, 0.013460861518979073, 0.06600882112979889, 0.1095261424779892, -0.05143499746918678, -0.03787413612008095, 0.18045499920845032, -0.003251305315643549, -1.0664897311129798e-32, -0.07425561547279358, 0.04400002211332321, -0.0531172975897789, -0.012192212045192719, -0.04974374175071716, -0.013003583066165447, 0.03981586545705795, 0.17950811982154846, -0.04591531306505203, -0.08265476673841476, -0.021182972937822342, 0.07500939071178436, -0.052394188940525055, 0.004183568060398102, 0.03370630368590355, -0.031111137941479683, 0.08304068446159363, -0.07568022608757019, 0.07572899758815765, -0.03590434044599533, -0.04326821118593216, 0.1769562065601349, -0.04002350568771362, 0.1871781051158905, 0.1426762491464615, 0.06010867655277252, 0.0676337257027626, 0.08437404781579971, -0.025029657408595085, -0.09371580928564072, 0.029175251722335815, -0.041515812277793884, -0.08880670368671417, 0.11729101091623306, -0.01274113915860653, -0.008016806095838547, 0.026803750544786453, -0.1576899141073227, 0.05005612224340439, -0.02605106681585312, 0.16799119114875793, 0.0522596575319767, 0.11590012907981873, -0.042939167469739914, 0.09567709267139435, 0.12027809023857117, 0.0684543177485466, 0.060178279876708984, 0.15882709622383118, 0.033245768398046494, 0.017591184005141258, 0.08236294984817505, -0.034183986485004425, 0.2254742980003357, -0.05503765493631363, 0.04853900521993637, -0.04730025678873062, -0.025097839534282684, -0.1845029890537262, 0.013899150304496288, -0.02443644031882286, 0.19923314452171326, 0.05884113907814026, 0.023050013929605484, 0.041917525231838226, -0.06481678038835526, -0.04948895424604416, -0.11473748832941055, -0.025174805894494057, -0.11196281015872955, 0.08269813656806946, -0.14558349549770355, -0.05107235535979271, -0.16738887131214142, -0.03507165610790253, 0.20445531606674194, 0.039595842361450195, -0.24563460052013397, -0.05565640702843666, -0.07461999356746674, -0.05187059938907623, 0.17084097862243652, 0.051883649080991745, -0.011805699206888676, -0.08868226408958435, 0.1513102650642395, -0.06537939608097076, -0.002954416908323765, 0.03682894632220268, -0.008231418207287788, 0.031141486018896103, -0.1260131448507309, -0.08489105105400085, 0.00044117681682109833, 0.1436602771282196, -9.985869553474913e-08, 0.03980807214975357, -0.028179574757814407, 0.0839870274066925, -0.031513117253780365, 0.17478451132774353, -0.09031367301940918, 0.09700826555490494, 0.011228635907173157, 0.07594288140535355, 0.06944327056407928, 0.14320144057273865, -0.02611549384891987, -0.10647985339164734, 0.04877648502588272, -0.08534222096204758, 0.010010497644543648, -0.0752459317445755, 0.006550552323460579, -0.034855328500270844, -0.15554466843605042, 0.012874051928520203, -0.008037321269512177, 0.14871612191200256, -0.04314698651432991, 0.04288835823535919, -0.12562139332294464, 0.018201148137450218, -0.03605132922530174, -0.05189592391252518, -0.054405659437179565, 0.016995899379253387, 0.003175176680088043, 0.07828262448310852, 0.04718354344367981, 0.021116839721798897, -0.08449916541576385, 0.03556586802005768, 0.05998896807432175, 0.03276868909597397, 0.07433110475540161, -0.04366207867860794, -0.07091706246137619, 0.09561333805322647, -0.03880591690540314, -0.11706005036830902, -0.025112677365541458, -0.17146211862564087, -0.036416418850421906, 0.01897951401770115, -0.2724636197090149, 0.034963805228471756, -0.07279056310653687, 0.002360682003200054, 0.0693851187825203, 0.03572489693760872, -0.0685848668217659, -0.22844551503658295, -0.0115608936175704, -0.07154945284128189, -0.058742307126522064, 0.13273514807224274, -0.24614210426807404, 0.02749747224152088, 0.1344645917415619], "changes": {"1wk": 0.707710028205947}}, {"text": "Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Net Revenue, Achieving Record Results at the Top of the Company\u2019s Guidance Business Wire Tue, Jan 21, 2025, 4:00 PM 10 min read In This Article: EOLS -7.09% Expects U.S. Approval Within 90 Days for Evolysse \u2122 Form and Evolysse \u2122 Smooth Injectable Hyaluronic Acid Gels Provides 2025 Guidance and Maintains Projection for Full-Year 2025 Profitability 1 Preliminary Unaudited Net Revenue of $79.0 Million for the Fourth Quarter 2024, Representing 30% Growth Over the Prior Year Preliminary Unaudited Net Revenue of $266.3 Million for the Full-Year 2024, Representing 32% Growth Over the Prior Year and at the Top of the Company\u2019s Guidance Expects U.S. Food and Drug Administration (FDA) Approval Within 90 Days for Evolysse \u2122 Form and Evolysse \u2122 Smooth Injectable Hyaluronic Acid (HA) Gels; U.S. Launch Planned for Q2 2025, A Full Quarter Ahead of Prior Timeline 2025 Net Revenue Guidance of $345 Million to $355 Million, Which Represents 30% to 33% Growth from Preliminary 2024 Results; Evolysse \u2122 and Estyme \u00ae Injectable HA Gels Anticipated to Contribute 8-10% of Total Revenue for the Full-Year 2025 2025 Non-GAAP Operating Expenses Expected to be $230 Million to $240 Million, with Expected Profitability 1 for the Full-Year 2025 NEWPORT BEACH, Calif., January 21, 2025 --( BUSINESS WIRE )-- Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio, today announced its preliminary, unaudited net revenue for the fourth quarter and full-year ended December 31, 2024. The preliminary unaudited results described in this press release are based on the most current information available to management and are subject to change until the audit of the company\u2019s 2024 financial results is completed and the company reports its full financial results for the fourth quarter and full-year 2024, which is anticipated to occur in early March 2025. \"The preliminary results for the fourth quarter and full-year 2024 underscore the strength of our operational execution and significant market share gains, driven by deeper penetration of the U.S. neurotoxin market with Jeuveau \u00ae and international expansion of Nuceiva \u00ae ,\" said David Moatazedi, President and Chief Executive Officer of Evolus. \"We exceeded 30% revenue growth for the fifth consecutive year, delivering results at multiples above the market, further validating our performance beauty approach and the effectiveness of our business model. These record results, at the top of our guidance, mark four years of achieving outcomes at or above our guidance and position us to build on this momentum and drive growth above 30% in 2025.\" \"Our U.S. filing for Evolysse \u2122 is ahead of schedule, and we now expect to receive FDA approval within the next 90 days. Next quarter, we will reach an important milestone, transitioning from a single product company to a multi-product innovator,\" Moatazedi continued. \"Our scalable cash-pay model, combined with a differentiated product portfolio, deep customer engagement, and leverageable infrastructure positions us for continued success. With the upcoming launch of Evolysse \u2122 injectable HA gels and sustained strength of Jeuveau \u00ae and Nuceiva \u00ae , our leadership in performance beauty continues to strengthen and we are well-positioned to achieve another year of over 30% revenue expansion. Looking beyond 2025, we are focused on achieving at least $700 million in net revenue and non-GAAP operating income margin of at least 20% by 2028, driven by our disciplined financial management and strategic investments.\" Story Continues Preliminary Unaudited 2024 Results and Key Business Highlights Total net revenues for the fourth quarter of 2024 were $79.0 million, a 30% increase over the fourth quarter of 2023, driven primarily by higher volumes and market share gains. Total net revenues for full-year 2024 were $266.3 million, a 32% percent increase over full-year net revenues in 2023, exceeding 30% growth for the fifth consecutive year, and at the top of the company\u2019s guidance of $260 million to $266 million. Accounts purchasing Jeuveau \u00ae increased by approximately 830 in the fourth quarter. This is approximately 20% above the year-to-date quarterly average in our seasonally highest performance quarter. During 2024, more than 2,900 new accounts were added bringing the total number of accounts purchasing to date since launch to more than 15,300, surpassing 50% account penetration in the U.S. The reorder rate among customers remains at approximately 70% 2 . Enrollment in the Evolus Rewards consumer loyalty program grew over 40% in 2024 to end the year at approximately 1.1 million consumers. 3 This was aided by a record high of approximately 220,000 total redemptions in the fourth quarter, driven by continued demand from existing patients receiving repeat treatments which represented approximately 60% of the total treatments for the quarter, demonstrating sustained brand loyalty. As of December 31, 2024, Evolus had cash and cash equivalents of $87.0 million compared to $85.0 million on September 30, 2024, reflecting strong sales growth, cash collections and prudent expense management. 2025 Guidance and Select Milestones Total net revenues for 2025 are estimated to be between $345 million and $355 million, which represents 30% to 33% growth from preliminary 2024 results. Evolysse \u2122 and Estyme \u00ae injectable HA gels are anticipated to contribute 8-10% of total revenue for the full-year 2025. Non-GAAP operating expenses for 2025 are estimated to be between $230 million and $240 million, driven primarily by continued investments in expanding Jeuveau \u00ae in the U.S., scaling Nuceiva \u00ae internationally, and supporting the U.S. launch for Evolysse \u2122 Form and Evolysse \u2122 Smooth injectable HA gels. Evolus expects to achieve positive non-GAAP operating income on a consolidated basis for the full-year 2025. Non-GAAP operating income is anticipated to be achieved after the launch of Evolysse \u2122 Form and Evolysse \u2122 Smooth injectable HA gels, with investments continuing to ramp in Q1 2025 and revenue contribution weighted toward the second half of the year, resulting in our non-GAAP operating income being concentrated in Q4 2025. The company expects U.S. FDA approval within 90 days for Evolysse \u2122 Form and Evolysse \u2122 Smooth injectable HA gels, with U.S. launch planned for Q2 2025, a full quarter ahead of the prior timeline. About Evolus, Inc. Evolus (NASDAQ: EOLS) is a global performance beauty company evolving the aesthetic neurotoxin market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global, multi-product aesthetics company based on our flagship product, Jeuveau \u00ae (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure\u2122 technology. Evolus is expanding its product portfolio having entered into a definitive agreement to be the exclusive U.S. distributor of Evolysse \u2122 , and the exclusive distributor in Europe of Estyme \u00ae , a line of unique injectable hyaluronic acid (HA) gels. These injectable HA gels are currently in the late stages of the regulatory approval process, with plans, upon approval, for a launch starting in 2025. Visit us at www.evolus.com , and follow us on LinkedIn , X , Instagram or Facebook . 1 \"Profitability\" is not a measure presented in accordance with GAAP. Within this press release, \"profitability\" is defined as achieving positive non-GAAP operating income. See \"Use of Non-GAAP Financial Measures\" below for more information on the company\u2019s use and definitions of non-GAAP measures. 2 Represents cumulative statistics from the launch of Jeuveau \u00ae in May 2019 through December 31, 2024. 3 Represents cumulative statistics from the launch of Evolus Rewards \u2122 in May 2020 through December 31, 2024. Use of Non-GAAP Financial Measures Evolus\u2019 financial results are prepared in accordance with accounting principles generally accepted in the United States of America (\"GAAP\"). This press release includes references to non-GAAP operating expenses, non-GAAP income (loss) from operations, and non-GAAP operating income margin which each exclude (i) the revaluation of contingent royalty obligations, (ii) stock-based compensation expense, and (iii) depreciation and amortization. Management believes that disclosure of non-GAAP operating expenses, non-GAAP income (loss) from operations, and non-GAAP operating income margin enables investors to assess the company in the same way that management assesses the company\u2019s operating performance against comparable companies with conventional accounting methodologies. The company\u2019s definitions of non-GAAP operating expenses, non-GAAP income (loss) from operations, and non-GAAP operating income margin have limitations as analytical tools and may differ from other companies reporting similarly named measures. Non-GAAP measures should not be considered superior to and are not intended to be considered in isolation or as a substitute for GAAP financial measures. Due to the forward-looking nature of the non-GAAP operating income and non-GAAP operating expenses outlook disclosed in this press release, a reconciliation of such non-GAAP measures to the comparable GAAP financial measures is not available without unreasonable efforts. This is due to the inherent difficulty of forecasting the timing or amount of various reconciling items that would impact the forward-looking non-GAAP financial measures since they have not yet occurred and/or cannot be reasonably predicted. Such unavailable information could have a significant impact on the company\u2019s GAAP financial results. Forward-Looking Statements This press release contains forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties, including statements about future or anticipated events, our business, financial condition, results of operations and prospects, our industry and the regulatory environment in which we operate. Any statements contained herein that are not statements of historical or current facts are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as \"anticipate,\" \"believe,\" \"could,\" \"estimate,\" \"expect,\" \"intend,\" \"may,\" \"plan,\" \"potential,\" \"predict,\" \"project,\" \"should,\" \"will,\" \"would\" or the negative of those terms, or other comparable terms intended to identify statements about the future. The company\u2019s forward-looking statements include, but are not limited to, statements related to anticipated product launches; market conditions and consumer demand; timing of regulatory submissions and approvals; the company\u2019s revenue and non-GAAP operating margin outlook and its financial outlook for 2025 and beyond; and the company\u2019s operational efficiency and leverage, cash position and expectations and timing for achieving profitability 1 and funding the company\u2019s operations. Additionally, the preliminary estimates of unaudited financial results as of and for the quarter and year ended December 31, 2024 are forward-looking statements and may differ materially from actual results. These estimates should not be viewed as a substitute for full interim or annual financial statements prepared in accordance with GAAP. Accordingly, you should not place undue reliance on this preliminary information. The preliminary financial information has been prepared by, and is the responsibility of, the company\u2019s management. The forward-looking statements included herein are based on our current expectations, assumptions, estimates and projections, which we believe to be reasonable, and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the forward-looking statements. These risks and uncertainties, all of which are difficult or impossible to predict accurately and many of which are beyond our control, include, but are not limited to uncertainties associated with our ability to comply with the terms and conditions in the Medytox Settlement Agreements, our ability to fund our future operations or obtain financing to fund our operations, unfavorable global economic conditions and the impact on consumer discretionary spending, uncertainties related to customer and consumer adoption of Jeuveau \u00ae and Evolysse \u2122 , the efficiency and operability of our digital platform, competition and market dynamics, our ability to successfully launch and commercialize our products in new markets, including the Evolysse \u2122 Hyaluronic Acid (HA) gels in the U.S., our ability to maintain regulatory approvals of Jeuveau \u00ae or obtain regulatory approvals for new product candidates or indications, our reliance on Symatese to achieve regulatory approval for the Evolysse \u2122 HA gel line in the U.S., and other risks described in our filings with the Securities and Exchange Commission, including in the section entitled \"Risk Factors\" in our Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 filed with the Securities and Exchange Commission on November 6, 2024. These filings can be accessed online at www.sec.gov . Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Except as required by law, we undertake no obligation to update or revise any forward-looking statements to reflect new information, changed circumstances or unanticipated events. If we do update or revise one or more of these statements, investors and others should not conclude that we will make additional updates or corrections. Jeuveau \u00ae and Nuceiva \u00ae , are registered trademarks and Evolysse \u2122 is a trademark of Evolus, Inc. Hi-Pure \u2122 is a trademark of Daewoong Pharmaceutical Co, Ltd. Estyme \u00ae is a trademark of Symatese Aesthetics S.A.S. View source version on businesswire.com: https://www.businesswire.com/news/home/20250121281026/en/ Contacts Evolus Contacts: Investors: Nareg Sagherian Vice President, Head of Global Investor Relations and Corporate Communications Tel: 248-202-9267 Email: ir@evolus.com Media : Email: media@evolus.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "EOLS", "date": "2025-01-21T16:00:00", "sentiment": {"score": 0.1545765893533826, "confidence": 0.1665276139974594, "probabilities": {"positive": 0.1665276139974594, "negative": 0.011951024644076824, "neutral": 0.8215213418006897}}, "embedding": [-0.07070919871330261, -0.057730622589588165, -0.025691471993923187, -0.0011521615087985992, -0.042124658823013306, -0.04034450650215149, -0.02909889817237854, 0.13437798619270325, 0.001944386400282383, -0.009736448526382446, 0.047990068793296814, 0.04269138723611832, -0.0180282574146986, -0.009865360334515572, -0.061678506433963776, 0.004680595360696316, 0.10333707928657532, -0.07849421352148056, -0.052891749888658524, 0.013153014704585075, 0.21154987812042236, -0.0514785572886467, -0.07750283181667328, -0.07084056735038757, -0.0021917661651968956, -0.023169903084635735, -0.07090025395154953, -0.001730525167658925, -0.13321420550346375, -0.16882199048995972, 0.03859711065888405, -0.030833816155791283, 0.023136205971240997, -0.17711986601352692, 0.10280501842498779, 0.01593385450541973, -0.14325538277626038, -0.03324326127767563, 0.0023063793778419495, -0.009358562529087067, -0.009116100147366524, -0.18306653201580048, -0.21539846062660217, 0.07480234652757645, -0.06630752235651016, -0.16092367470264435, 0.07268327474594116, 0.014035642147064209, -0.04355619102716446, 0.09928140789270401, -0.0684674084186554, -0.14299224317073822, 0.07606104016304016, -0.09280164539813995, -0.15238340198993683, 0.022482700645923615, -0.1753697544336319, -0.048790451139211655, -0.05623028799891472, -0.022397849708795547, -0.0709085613489151, 0.035061031579971313, -0.03638666868209839, 0.10201264917850494, 0.03263520449399948, -0.034466564655303955, 0.10684415698051453, -0.049048300832509995, -0.0865064412355423, -0.01886874996125698, 0.11969928443431854, -0.10021588206291199, -0.03364609181880951, 0.008237328380346298, 0.03305961191654205, 0.19953680038452148, 0.21543598175048828, 0.12149173021316528, 0.1074257418513298, -0.11349955201148987, 0.11590538918972015, 0.032691583037376404, 0.00092361681163311, -0.05466831475496292, -0.031452905386686325, 0.06377817690372467, 0.03318636491894722, 0.05394797772169113, 0.07184125483036041, 0.13245747983455658, 0.1566580832004547, -0.11643831431865692, -0.008718311786651611, -0.000923466868698597, 0.053366780281066895, 0.021762948483228683, -0.09788884222507477, -0.0977448895573616, 0.013292582705616951, 0.061278920620679855, -0.008922436274588108, 0.12468849122524261, -0.055753931403160095, -0.15596933662891388, -0.030542388558387756, -0.057727813720703125, 0.02781788632273674, 0.01998152583837509, 0.1223728209733963, 0.015775641426444054, -0.08532827347517014, -0.03268127888441086, -0.004292752593755722, -0.01880795694887638, -0.05224606394767761, 0.19207429885864258, -0.04511181265115738, 0.039253558963537216, 0.27029216289520264, -0.10990678519010544, 0.07852652668952942, 0.06208357959985733, 0.05422547832131386, -0.02026853710412979, -0.047056298702955246, -0.05313640832901001, -0.0785779133439064, 1.4393753471034226e-32, -0.1012936383485794, 0.043406132608652115, 0.03095281310379505, -0.05495079606771469, -0.06719314306974411, 0.10345286130905151, 0.03490585833787918, 0.07604982703924179, -0.08856020867824554, -0.03173288702964783, -0.23402036726474762, 0.08897513896226883, -0.00038338033482432365, 0.12479156255722046, 0.030151676386594772, -0.15043210983276367, -0.03904661536216736, 0.1624031811952591, 0.07083164155483246, -0.0010068491101264954, 0.001518934965133667, -0.06911499053239822, 0.022774389013648033, 0.10075737535953522, -0.08305133879184723, 0.14583764970302582, -0.022392164915800095, -0.05347610265016556, 0.0015531554818153381, 0.0752207487821579, 0.004080027341842651, 0.03295384719967842, 0.05470912903547287, -0.07302692532539368, -0.12249782681465149, -0.020991969853639603, -0.026667216792702675, -0.07204936444759369, 0.11759597063064575, -0.035640474408864975, -0.02142239920794964, 0.12979340553283691, -0.00872889719903469, -0.058963943272829056, -0.04366902634501457, -0.027185630053281784, 0.037628594785928726, 0.03156089037656784, -0.005039583891630173, -0.03745628520846367, -0.0378141924738884, 0.05683299899101257, 0.04024586081504822, -0.1088932603597641, 0.00411252724006772, 0.009530366398394108, -0.09201357513666153, 0.03735901042819023, 0.09489166736602783, 0.06247405707836151, -0.06261483579874039, 0.22786733508110046, -0.05571451038122177, -0.02809828519821167, -0.13249394297599792, 0.18456557393074036, 0.01144973374903202, -0.11405936628580093, -0.021595751866698265, -0.019304469227790833, 0.0011402224190533161, -0.03220509737730026, 0.14840783178806305, -0.08958826214075089, 0.15505462884902954, -0.03633205220103264, 0.04044410586357117, 0.021842390298843384, 0.12315739691257477, 0.017743311822414398, -0.0876607671380043, 0.035682253539562225, -0.058672331273555756, 0.01789533905684948, 0.12548351287841797, -0.03857121616601944, 0.06324128061532974, 0.10449668765068054, -0.005073229782283306, 0.09048470854759216, 0.0997573584318161, -0.0999985858798027, -0.04061916470527649, 0.15338316559791565, -0.008020279929041862, -1.272405043839954e-32, -0.028351835906505585, -0.011154974810779095, -0.05296529084444046, 0.004818109795451164, 0.09379123151302338, -0.002739417366683483, 0.11160329729318619, 0.1661427617073059, 0.026487883180379868, -0.06086415797472, 0.049393050372600555, 0.06960679590702057, 0.009636564180254936, -0.006550353951752186, -0.049488335847854614, -0.011791322380304337, -0.011290445923805237, -0.12564286589622498, 0.0034266049042344093, 0.058566510677337646, 0.017041165381669998, 0.2540839612483978, -0.012225208804011345, 0.10161754488945007, 0.0883929654955864, 0.09822292625904083, 0.027417486533522606, 0.07393753528594971, 0.0056260619312524796, 0.004055788274854422, -0.04235796630382538, -0.02892741933465004, -0.17457304894924164, 0.0741613358259201, -0.11497495323419571, 0.009919862262904644, 0.056523680686950684, -0.09077757596969604, 0.037311285734176636, -0.05940937250852585, 0.10534730553627014, -0.0924406349658966, -0.04200728237628937, -0.011848236434161663, 0.05128786712884903, 0.08272358775138855, -0.0138277318328619, -0.052769944071769714, 0.09989768266677856, 0.05770697444677353, -0.0277088675647974, 0.1229073703289032, -0.15370868146419525, 0.1258070021867752, -0.09159761667251587, 0.0043808044865727425, -0.051665328443050385, -0.03672832250595093, -0.1738770306110382, 0.02906220033764839, -0.03293126821517944, 0.16513003408908844, 0.0839458554983139, 0.024959824979305267, 0.0648043230175972, 0.008098459802567959, 0.03838665038347244, -0.034853264689445496, 0.03298172727227211, -0.20106685161590576, 0.03105868399143219, -0.01752260886132717, -0.09141311049461365, -0.14404943585395813, 0.08187680691480637, 0.09923084825277328, 0.0813991129398346, -0.20127004384994507, -0.06236181780695915, -0.16900494694709778, -0.08629160374403, 0.06548610329627991, -0.005551360081881285, 0.03758196905255318, 0.05107472091913223, 0.08020982891321182, 0.010924024507403374, -0.031926751136779785, 0.01607608050107956, 0.12492775171995163, -0.06452950835227966, -0.06844407320022583, -0.02572174370288849, 0.19480814039707184, 0.2054017335176468, -1.0006630191128352e-07, 0.1065693199634552, 0.06416347622871399, 0.14583654701709747, -0.043981049209833145, 0.11874380707740784, -0.12598954141139984, 0.031014062464237213, 0.0892455130815506, -0.00018310174345970154, 0.03897719830274582, 0.06748782098293304, 0.1080005019903183, -0.05316082015633583, 0.0634826198220253, -0.1143285483121872, 0.07868172973394394, -0.04335813969373703, 0.1576341688632965, -0.12432987242937088, -0.1785719394683838, -0.08776743710041046, 0.03398052230477333, 0.011396139860153198, -0.06062266230583191, 0.012895021587610245, -0.1679980754852295, -0.007142068352550268, -0.02626131661236286, -0.048075269907712936, -0.022484231740236282, 0.0469086691737175, 0.018136709928512573, 0.05288472771644592, -0.0029984014108777046, -0.08461347222328186, -0.17723995447158813, -0.09950809180736542, 0.040771935135126114, -0.0027349949814379215, 0.05111298710107803, -0.09176549315452576, -0.06300804764032364, 0.06407370418310165, 0.002769244834780693, -0.016106802970170975, -0.1128007173538208, -0.161661297082901, 0.017496226355433464, 0.05826370790600777, -0.031247448176145554, -0.02298794500529766, -0.07525791972875595, -0.0656386986374855, -0.09440085291862488, 0.10862140357494354, -0.06723178923130035, -0.0467965304851532, -0.03933991491794586, -0.0398070402443409, 0.04284537583589554, 0.0818946585059166, -0.23622335493564606, 0.1342143416404724, 0.017227359116077423], "changes": {"1wk": 9.495554377690699}}, {"text": "Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere \u2014 Here's Why Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere \u2014 Here's Why \u00b7 Investor's Business Daily ALLISON GATLIN Wed, Jan 22, 2025, 12:04 AM 2 min read In This Article: ABBV +3.39% EOLS -7.09% Shares of Evolus made a doubly bullish move Tuesday on a strong preliminary fourth-quarter report and guidance for 2025. Continue Reading View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "EOLS", "date": "2025-01-22T00:04:48", "sentiment": {"score": 0.5892218314111233, "confidence": 0.6106404066085815, "probabilities": {"positive": 0.6106404066085815, "negative": 0.021418575197458267, "neutral": 0.3679410219192505}}, "embedding": [-0.02543768286705017, -0.09851761907339096, 0.0007687125471420586, 0.0607973076403141, 0.04653036594390869, 0.0648973286151886, -0.04726723954081535, 0.10324611514806747, 0.04016565904021263, 0.0036229738034307957, 0.04253845289349556, 0.04995724558830261, -0.01755312830209732, -0.1038532480597496, 0.10451804101467133, 0.0303130354732275, 0.10690901428461075, -0.3250940442085266, -0.02820274978876114, 0.025761887431144714, -0.0781359151005745, -0.08967280387878418, 0.02963494509458542, 0.06974726915359497, 0.07717972993850708, 0.05638037621974945, -0.11109063029289246, 0.03791455551981926, -0.02778661623597145, -0.1985362321138382, 0.08998417854309082, -0.0026493410114198923, 0.03885690122842789, -0.0828273668885231, 0.03940082713961601, -0.027262844145298004, -0.13408486545085907, -0.020992496982216835, 0.0632491409778595, 0.02678731642663479, -0.0005139799905009568, -0.13279542326927185, -0.0689888522028923, 0.12231532484292984, -0.15353992581367493, -0.12825649976730347, 0.1374569684267044, 0.07559464126825333, 0.11686959862709045, 0.04240734875202179, 0.011487041600048542, -0.16157743334770203, 0.11527092009782791, -0.17355982959270477, -0.040714047849178314, 0.17006681859493256, -0.17851828038692474, -0.07932033389806747, 0.11355836689472198, -0.004121681209653616, 0.010706954635679722, 0.09104366600513458, 0.033990006893873215, 0.18249107897281647, 0.03804265335202217, -0.035915397107601166, 0.08355021476745605, 0.04096735641360283, -0.162175714969635, 0.06507780402898788, 0.15387825667858124, -0.08917371183633804, -0.002032050397247076, -0.041780877858400345, -0.1357865333557129, 0.20994342863559723, 0.10309874266386032, -0.0981857180595398, 0.14399732649326324, -0.05792438983917236, 0.0542527474462986, -0.22982318699359894, -0.035733774304389954, 0.043480873107910156, -0.11729234457015991, 0.09595387428998947, 0.08718740195035934, -0.14382699131965637, -0.07994023710489273, 0.07351592928171158, 0.09950792044401169, -0.1360812485218048, 0.12619322538375854, 0.03812975808978081, 0.05803089216351509, 0.15473715960979462, -0.12482156604528427, -0.08622672408819199, -0.02711384743452072, 0.02262507937848568, -0.05615673214197159, 0.11073222756385803, -0.09414773434400558, -0.007071631960570812, -0.08050361275672913, -0.14854544401168823, 0.0943908840417862, 0.017638077959418297, 0.20214508473873138, -0.017507756128907204, -0.08893056958913803, -0.023751920089125633, 0.025662750005722046, -0.017109772190451622, 0.01634485274553299, 0.1328584998846054, 0.018690776079893112, 0.07922794669866562, 0.02313193678855896, -0.14533750712871552, 0.07464997470378876, 0.11727452278137207, -0.02763178013265133, 0.03540677949786186, 0.025032568722963333, -0.13418221473693848, 0.11269642412662506, 1.254736335189538e-32, 0.044612783938646317, -0.052815813571214676, -0.06840723752975464, 0.08095576614141464, -0.0752343162894249, 0.20627543330192566, -0.18753886222839355, 0.03034053184092045, -0.1378713697195053, -0.02441723272204399, -0.35105493664741516, 0.07154672592878342, 0.033514704555273056, 0.15396834909915924, -0.06262818723917007, -0.16019493341445923, -0.1635545790195465, 0.028572313487529755, 0.034794799983501434, -0.09179496765136719, 0.08623818308115005, -0.08288613706827164, -0.0004050281422678381, 0.19723309576511383, -0.12722527980804443, 0.17922855913639069, 0.021449903026223183, 0.005501276347786188, -0.013526092283427715, 0.128461554646492, -0.02740386687219143, 0.13386350870132446, -0.16805177927017212, 0.025131413713097572, -0.10638739913702011, 0.09388905763626099, -0.16488800942897797, -0.12777018547058105, -0.16598066687583923, -0.04060298949480057, -0.18441368639469147, 0.09263160824775696, -0.38390877842903137, -0.09762407839298248, 0.1183180958032608, -0.06667383015155792, -0.03622082620859146, -0.11748389899730682, 0.061569903045892715, -0.029121004045009613, -0.06261783838272095, 0.14405788481235504, 0.05706379562616348, -0.0907740667462349, 0.1058972030878067, -0.0073117539286613464, -0.05245249718427658, 0.00021153110719751567, 0.058764804154634476, 0.07185373455286026, 0.18999826908111572, 0.2922745943069458, 0.026755573228001595, -0.1354808211326599, -0.02205730602145195, 0.38060885667800903, 0.06544755399227142, -0.024145089089870453, -0.1557639092206955, -0.03562203049659729, 0.14694145321846008, 0.08070458471775055, -0.03134046867489815, -0.09998662769794464, 0.10866696387529373, 0.022256862372159958, -0.11919363588094711, 0.039644237607717514, 0.15400934219360352, -0.10389164835214615, -0.11439149081707001, -0.0971398651599884, 0.30748698115348816, -0.0632939338684082, 0.1684195101261139, -0.09585005044937134, -0.1529390811920166, 0.062250591814517975, -0.05120311304926872, 0.13934385776519775, -0.0017343171639367938, -0.084666907787323, -0.02022227644920349, 0.13209182024002075, -0.011038287542760372, -1.3312740948027218e-32, -0.1523837298154831, -0.03615007922053337, -0.03322283923625946, -0.05253540724515915, 0.0606379359960556, 0.028945231810212135, 0.09195570647716522, 0.19460728764533997, 0.11375656723976135, 0.14658968150615692, -0.11161600053310394, 0.07069233059883118, -0.048100750893354416, -0.08765964210033417, 0.18027526140213013, -0.05276567488908768, 0.004281236790120602, -0.14411865174770355, -0.039608027786016464, 0.0124988853931427, -0.06134265288710594, 0.08911242336034775, -0.05638674646615982, 0.15758593380451202, 0.157220259308815, 0.08689043670892715, 0.06132984161376953, -0.06888546049594879, 0.03144199028611183, -0.09854911267757416, -0.046082496643066406, 0.11815232783555984, -0.109051413834095, 0.08287353813648224, -0.04788590967655182, 0.20544955134391785, -0.06910557299852371, 0.07983579486608505, -0.09213034808635712, -0.2525841295719147, -0.04064266011118889, 0.08053169399499893, -0.05654473230242729, -0.15951398015022278, 0.22180208563804626, 0.12662039697170258, -0.15390275418758392, 0.02645811066031456, 0.10062269866466522, 0.05604374036192894, -0.028248677030205727, 0.07269644737243652, 0.0992523804306984, 0.10609487444162369, 0.05632185935974121, -0.09221933782100677, -0.08145502209663391, 0.013285156339406967, -0.1046350970864296, -6.631461292272434e-05, 0.09313006699085236, 0.05480453744530678, 0.07818278670310974, 0.11209780722856522, -0.06713081151247025, -0.0061846231110394, 0.03503309190273285, 0.04068826138973236, -0.06483080983161926, -0.10827904939651489, 0.2132742553949356, -0.05569897219538689, -0.2869291305541992, -0.10846806317567825, -0.036421749740839005, 0.13693034648895264, -0.0034165573306381702, -0.15717008709907532, -0.04303186014294624, -0.10536916553974152, -0.06794996559619904, 0.17518223822116852, 0.14333394169807434, 0.07181282341480255, 0.021409738808870316, 0.12442468106746674, -0.07042402774095535, -0.13599088788032532, 0.09060931205749512, 0.13297204673290253, -0.11363814026117325, -0.06552141159772873, -0.07571353763341904, -0.0437810942530632, 0.16281788051128387, -9.942925771611044e-08, 0.06881489604711533, 0.12960079312324524, 0.2850910425186157, 0.014406923204660416, 0.16404014825820923, 0.03475391864776611, 0.023583877831697464, 0.10710502415895462, 0.11714690923690796, 0.12193954735994339, -0.04574887827038765, 0.03686990216374397, 0.07078045606613159, 0.03214329108595848, -0.06684882193803787, 0.06694840639829636, -0.13112090528011322, -0.005532992538064718, 0.010869855061173439, -0.01096426136791706, -0.11385443806648254, -0.06434938311576843, 0.10165222734212875, -0.0351310558617115, 0.062909334897995, -0.08523936569690704, -0.05391457676887512, -0.033243101090192795, 0.061446722596883774, -0.07637573033571243, -0.07269041985273361, 0.05506732687354088, 0.008780059404671192, -0.1556096076965332, -0.14640597999095917, -0.039188917726278305, 0.07798949629068375, 0.048959385603666306, 0.008793382905423641, 0.009877949953079224, -0.1587064266204834, -0.1355830878019333, 0.18386855721473694, -0.05003126338124275, -0.016118433326482773, 0.01041779201477766, -0.10579466074705124, -0.13162386417388916, 0.030710911378264427, -0.025462377816438675, 0.009226187132298946, -0.18120528757572174, -0.11969733983278275, 0.12050050497055054, -0.002569408155977726, -0.11185003072023392, -0.19400517642498016, -0.08528538793325424, -0.04953824356198311, -0.10538455098867416, 0.11409856379032135, -0.2026897668838501, 0.029013637453317642, 0.058753468096256256], "changes": {"1wk": 5.563798408524094}}, {"text": "Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire Sat, Jan 18, 2025, 12:05 AM 2 min read In This Article: EOLS -7.09% NEWPORT BEACH, Calif., January 17, 2025 --( BUSINESS WIRE )-- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant in January of an aggregate of 15,332 restricted stock units (RSUs) of the company\u2019s common stock to 6 newly hired non-executive employees of the company. The awards were approved by the compensation committee of the company\u2019s board of directors under the Evolus\u2019 2023 Inducement Incentive Plan, with a grant date and vesting commencement date of January 7, 2025, as an inducement material to the new employees entering into employment with Evolus in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs vest 25% on each annual anniversary of the vesting commencement date. The awards are subject to the terms and conditions of the 2023 Inducement Incentive Plan and the terms and conditions of the stock option agreement or RSU agreement, as applicable, covering the grant, including requirements to remain continuously employed on each vesting date. About Evolus, Inc. Evolus (NASDAQ: EOLS) is a global performance beauty company evolving the aesthetic neurotoxin market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global, multi-product aesthetics company based on our flagship product, Jeuveau \u00ae (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure\u2122 technology. Evolus is expanding its product portfolio having entered into a definitive agreement to be the exclusive U.S. distributor of Evolysse \u2122 , and the exclusive distributor in Europe of Estyme \u00ae , a line of unique injectable hyaluronic acid (HA) gels. These injectable HA gels are currently in the late stages of the regulatory approval process, with plans, upon approval, for a launch starting in 2025. Visit us at www.evolus.com , and follow us on LinkedIn , X , Instagram or Facebook . Jeuveau \u00ae and Nuceiva \u00ae , are registered trademarks and Evolysse \u2122 is a trademark of Evolus, Inc. Hi-Pure \u2122 is a trademark of Daewoong Pharmaceutical Co, Ltd. Estyme \u00ae is a trademark of Symatese Aesthetics S.A.S. View source version on businesswire.com: https://www.businesswire.com/news/home/20250117719857/en/ Contacts Evolus Contacts: Investors: Nareg Sagherian Vice President, Head of Global Investor Relations and Corporate Communications Tel: 248-202-9267 Email: ir@evolus.com Media: Email: media@evolus.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "EOLS", "date": "2025-01-18T00:05:00", "sentiment": {"score": 0.2128547476604581, "confidence": 0.2198614478111267, "probabilities": {"positive": 0.2198614478111267, "negative": 0.007006700150668621, "neutral": 0.7731318473815918}}, "embedding": [-0.09717769920825958, -0.02334935963153839, -0.06911764293909073, -0.05878641828894615, -0.04231448471546173, 0.056196510791778564, 0.018445046618580818, 0.08662278950214386, 0.04000306874513626, -0.027281757444143295, 0.11443977057933807, 0.021542908623814583, 0.07762052118778229, 0.03510930389165878, 0.0211435928940773, -0.015000988729298115, 0.11856023967266083, 0.01990646868944168, -0.07832137495279312, -0.020481515675783157, 0.14160563051700592, -0.05635807663202286, -0.09422124922275543, -0.03870725259184837, -0.039531584829092026, -0.054782524704933167, -0.0618327334523201, 0.0457143634557724, -0.0768757313489914, -0.12248919904232025, 0.035392649471759796, 0.012570749968290329, 0.005607525818049908, -0.1887873411178589, 0.001157839666120708, 0.00802572537213564, -0.23673667013645172, -0.09799084067344666, -0.07432088255882263, -0.052670348435640335, -0.05077563226222992, -0.1007315069437027, -0.17356479167938232, 0.06654511392116547, -0.060983702540397644, -0.10709671676158905, 0.07739736139774323, -0.0065263379365205765, -0.03204920515418053, 0.021324533969163895, -0.03418556973338127, -0.13396760821342468, 0.07706485688686371, -0.021780112758278847, -0.11760313808917999, 0.029801135882735252, -0.20113816857337952, -0.07764237374067307, -0.010566613636910915, 0.006976354401558638, 0.0013328292407095432, 0.031062224879860878, -0.03357690945267677, 0.11302943527698517, 0.041011735796928406, -0.04994680732488632, 0.09290039539337158, -0.03990400582551956, -0.04379019886255264, -0.051727596670389175, 0.1370810866355896, -0.15401378273963928, 0.025574734434485435, 0.06264406442642212, 0.05383610725402832, 0.2970896363258362, 0.11179791390895844, 0.06783251464366913, 0.11561496555805206, -0.19521765410900116, -0.022549167275428772, 0.0823177769780159, 0.04352802783250809, 0.0452209897339344, -0.014469638466835022, 0.027374789118766785, 0.01168767735362053, -0.021619411185383797, 0.035986121743917465, 0.11900800466537476, 0.12431816011667252, -0.06750589609146118, 0.0007008006796240807, -0.04695386439561844, 0.03592365235090256, -0.027592718601226807, -0.15837877988815308, 0.0011670701205730438, -0.007247537840157747, 0.06356452405452728, -0.07820533961057663, 0.13800132274627686, -0.07367348670959473, -0.005796518176794052, -0.08444954454898834, -0.03740858659148216, -0.06383765488862991, -0.009140485897660255, 0.11038441956043243, -0.018620776012539864, -0.09164779633283615, -0.03727152198553085, -0.007207509130239487, -0.0790221095085144, -0.1289234757423401, 0.1575128585100174, -0.011970877647399902, 0.0683315247297287, 0.2657162547111511, -0.13807478547096252, 0.10768253356218338, 0.030091190710663795, 0.047722384333610535, -0.09600690007209778, 0.02118377573788166, -0.037745364010334015, -0.09228833019733429, 6.830951221577889e-33, -0.08310163021087646, -0.019866550341248512, 0.03373967111110687, -0.00146404467523098, -0.01951984129846096, -0.02012147568166256, 0.0023533497005701065, 0.04459004104137421, -0.06519979238510132, 0.08696773648262024, -0.2166682332754135, 0.1480472981929779, 0.0053633712232112885, 0.14525973796844482, 0.04049493372440338, -0.10880930721759796, -0.043898262083530426, 0.10601187497377396, 0.05949854105710983, 0.03621431440114975, 0.038543760776519775, 0.027708902955055237, 0.09155130386352539, 0.1263149529695511, -0.00022895494475960732, 0.07546645402908325, -0.023776859045028687, -0.032899342477321625, -0.03647129237651825, 0.10783226788043976, 0.03095177561044693, 0.07404878735542297, 0.014803087338805199, -0.05809738114476204, -0.11699479073286057, -0.01422370970249176, -0.042142413556575775, -0.16288717091083527, 0.07072567194700241, -0.09137735515832901, -0.018914971500635147, 0.03792554512619972, -0.09415895491838455, -0.03665117919445038, -0.020063813775777817, 0.0350567102432251, 0.0570504292845726, 0.01971380040049553, 0.04599078372120857, 0.07416528463363647, -0.059553131461143494, 0.04742421954870224, 0.12574560940265656, -0.07492884993553162, -0.06350358575582504, -0.005941161885857582, -0.07684149593114853, 0.09673240780830383, 0.14186760783195496, 0.08625222742557526, -0.148319274187088, 0.244606614112854, -0.06171862781047821, 0.023069102317094803, -0.05317762866616249, 0.13035842776298523, 0.029762260615825653, -0.12731309235095978, -0.005775676108896732, -0.0927811786532402, 0.009088611230254173, 0.03736789897084236, 0.09056803584098816, -0.10281901806592941, 0.036086294800043106, -0.08547143638134003, 0.014829265885055065, 0.09108883887529373, 0.07724346220493317, -0.09873327612876892, -0.11167941987514496, 0.07702327519655228, -0.07777334004640579, 0.003915558569133282, 0.17704838514328003, -0.016899384558200836, -0.009802748449146748, 0.1260780543088913, 0.026899822056293488, 0.002327871508896351, 0.15143153071403503, -0.03189102187752724, 0.04941235110163689, 0.20769312977790833, 0.0036330102011561394, -5.528645274872862e-33, -0.061580415815114975, -0.0906822606921196, -0.06753723323345184, -0.0011622831225395203, 0.14852432906627655, 0.047670863568782806, 0.04327442869544029, 0.06881217658519745, -0.005149761214852333, -0.057251036167144775, 0.008416514843702316, 0.06481665372848511, -0.031339455395936966, -0.040446214377880096, -0.021753251552581787, 0.04458476975560188, -0.06615304946899414, -0.08385255932807922, -0.10196448862552643, 0.08396469801664352, 0.051634401082992554, 0.26175621151924133, -0.050272077322006226, 0.06808622181415558, 0.15443724393844604, 0.06630788743495941, 0.04274832084774971, 0.09717412292957306, 0.029743125662207603, 0.014834275469183922, -0.09433262050151825, 0.013963760808110237, -0.2597174346446991, 0.08247645944356918, -0.0028491122648119926, -0.041907571256160736, 0.10709263384342194, -0.0726192519068718, 0.05006521940231323, 0.010951303876936436, 0.04852032661437988, -0.03332596644759178, -0.0018203319050371647, 0.05490567535161972, 0.07095848768949509, 0.023531757295131683, 0.004544246941804886, -0.16020649671554565, 0.06575243175029755, 0.03784946724772453, -0.025409642606973648, 0.07598923146724701, 0.08739083260297775, 0.11916284263134003, -0.02791959047317505, -0.08111415803432465, 0.010080953128635883, -0.027605831623077393, -0.022235125303268433, 0.06408146768808365, 0.060018569231033325, 0.07462520152330399, 0.027804875746369362, 0.07997442036867142, 0.07884567975997925, -0.02099345624446869, 0.06300995498895645, -0.03431708365678787, -0.07629908621311188, -0.1083383560180664, 0.06575115025043488, -0.035869449377059937, -0.05923806130886078, -0.17253637313842773, 0.003975076600909233, 0.020663399249315262, 0.04516447335481644, -0.12067888677120209, -0.14305046200752258, -0.12644818425178528, -0.08518047630786896, 0.018163684755563736, 0.02266482077538967, 0.06077469140291214, 0.14703433215618134, 0.07493684440851212, -0.00730251707136631, -0.004838746041059494, 0.07336699962615967, 0.067425936460495, -0.039544131606817245, -0.028283867985010147, -0.03070533648133278, 0.20471437275409698, 0.11659315973520279, -9.969315328817174e-08, 0.08077415823936462, -0.00415171030908823, 0.02788182534277439, -0.12351034581661224, 0.19303220510482788, -0.166456401348114, -0.029882997274398804, 0.08500678092241287, -0.06034376099705696, 0.05344141274690628, 0.17201071977615356, 0.1548636257648468, -0.06441923975944519, 0.020021244883537292, -0.05737650394439697, 0.06545192003250122, -0.0011294158175587654, 0.12189093232154846, -0.11697733402252197, -0.10018929839134216, -0.033292654901742935, -0.021156545728445053, 0.014324469491839409, -0.08217643201351166, -0.009911024942994118, -0.17760461568832397, 0.08223038911819458, -0.0424722395837307, -0.036799103021621704, -0.04121197387576103, 0.007986904121935368, 0.06312207877635956, 0.06874898076057434, -0.03842897713184357, -0.060675811022520065, -0.10725820064544678, 0.08826063573360443, 0.0373360700905323, -0.042573027312755585, 0.05045260861515999, -0.11733673512935638, -0.07347743213176727, 0.048785507678985596, -0.03297468274831772, -0.03705357387661934, 0.025836758315563202, -0.19097259640693665, -0.0056664785370230675, -0.022310292348265648, -0.0009269341826438904, -0.0721009224653244, -0.06015007570385933, -0.11294722557067871, -0.036660127341747284, -0.03958000987768173, -0.08889366686344147, -0.008767450228333473, -0.07639053463935852, 0.05474738031625748, -0.016579650342464447, 0.09785319119691849, -0.10794566571712494, 0.16872641444206238, 0.01866871863603592], "changes": {"1wk": 35.39485473208467}}, {"text": "Evolus, Inc.'s (NASDAQ:EOLS) Path To Profitability editorial-team@simplywallst.com (Simply Wall St) Fri, Dec 20, 2024, 1:39 PM 3 min read In This Article: EOLS -7.09% Evolus, Inc. ( NASDAQ:EOLS ) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The US$702m market-cap company\u2019s loss lessened since it announced a US$62m loss in the full financial year, compared to the latest trailing-twelve-month loss of US$55m, as it approaches breakeven. As path to profitability is the topic on Evolus' investors mind, we've decided to gauge market sentiment. In this article, we will touch on the expectations for the company's growth and when analysts expect it to become profitable. View our latest analysis for Evolus Consensus from 6 of the American Pharmaceuticals analysts is that Evolus is on the verge of breakeven. They anticipate the company to incur a final loss in 2025, before generating positive profits of US$16m in 2026. The company is therefore projected to breakeven around 2 years from now. In order to meet this breakeven date, we calculated the rate at which the company must grow year-on-year. It turns out an average annual growth rate of 74% is expected, which signals high confidence from analysts. If this rate turns out to be too aggressive, the company may become profitable much later than analysts predict. NasdaqGM:EOLS Earnings Per Share Growth December 20th 2024 We're not going to go through company-specific developments for Evolus given that this is a high-level summary, but, bear in mind that by and large a pharma company has lumpy cash flows which are contingent on the drug and stage of product development the business is in. This means that a high growth rate is not unusual, especially if the company is currently in an investment period. Before we wrap up, there\u2019s one issue worth mentioning. Evolus currently has a debt-to-equity ratio of over 2x. Generally, the rule of thumb is debt shouldn\u2019t exceed 40% of your equity, and the company has considerably exceeded this. A higher level of debt requires more stringent capital management which increases the risk around investing in the loss-making company. Next Steps: There are too many aspects of Evolus to cover in one brief article, but the key fundamentals for the company can all be found in one place \u2013 Evolus' company page on Simply Wall St . We've also compiled a list of key factors you should further examine: Valuation : What is Evolus worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether Evolus is currently mispriced by the market. Management Team : An experienced management team on the helm increases our confidence in the business \u2013 take a look at who sits on Evolus\u2019s board and the CEO\u2019s background . Other High-Performing Stocks : Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here . Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "EOLS", "date": "2024-12-20T13:39:15", "sentiment": {"score": 0.3832981809973717, "confidence": 0.42489129304885864, "probabilities": {"positive": 0.42489129304885864, "negative": 0.04159311205148697, "neutral": 0.5335156321525574}}, "embedding": [-0.04311991482973099, -0.04748822748661041, -0.04231629520654678, -0.0034344231244176626, 0.038236770778894424, -0.023900926113128662, -0.02650313265621662, 0.1600804477930069, 0.12451329827308655, 0.03634053096175194, -0.05896665155887604, 0.0649675577878952, 0.006187239196151495, -0.0243703480809927, -0.027026604861021042, -0.04017085209488869, -0.0018921997398138046, -0.11437579989433289, -0.1128435879945755, 0.043440721929073334, 0.03755129873752594, -0.09732165932655334, -0.004964685998857021, -0.03715340048074722, 0.010154866613447666, -0.019916798919439316, 0.020999843254685402, 0.01622490957379341, -0.1262379288673401, -0.07675357908010483, 0.054134055972099304, 0.09044276177883148, 0.10747762024402618, -0.11507128179073334, -0.022634640336036682, -0.03511688485741615, -0.10202205181121826, 0.0178162083029747, 0.04472631588578224, -0.0277226772159338, -0.03487153723835945, -0.030470333993434906, -0.11921173334121704, 0.023875949904322624, -0.01863865926861763, -0.22724780440330505, 0.05282013118267059, 0.018514588475227356, 0.03477583825588226, 0.04799185320734978, -0.14983639121055603, -0.08119052648544312, -0.00195970106869936, -0.05962470918893814, -0.05632910877466202, 0.033253904432058334, -0.14426913857460022, -0.13742977380752563, 0.01554658729583025, 0.025099022313952446, 0.04193780571222305, 0.044332049787044525, 0.00842689722776413, 0.06668344885110855, 0.15015023946762085, -0.05905124172568321, 0.14457139372825623, 0.04776143282651901, -0.21411380171775818, 0.09815722703933716, 0.05074071139097214, -0.13534539937973022, -0.09043039381504059, -0.01698111928999424, -0.017456619068980217, 0.18113356828689575, 0.09844359755516052, 0.04910402372479439, 0.06849468499422073, -0.07134594023227692, 0.07625089585781097, -9.564682841300964e-06, -0.08378289639949799, -0.1451667845249176, -0.10939821600914001, -0.02027643285691738, 0.14900988340377808, -0.04360392317175865, 0.12645159661769867, 0.07718970626592636, 0.09723129868507385, -0.09036354720592499, -0.07582488656044006, 0.022543951869010925, 0.1618405431509018, 0.17116978764533997, -0.11185287684202194, -0.10848960280418396, 0.004470733925700188, 0.034182075411081314, 0.10128998011350632, 0.14398899674415588, -0.02584349364042282, -0.11252905428409576, -0.08729873597621918, -0.10279892385005951, 0.015788711607456207, -0.015087667852640152, 0.02409479394555092, 0.06872472167015076, -0.07509439438581467, 0.0347607247531414, -0.0667753517627716, -0.056496091187000275, -0.003008393570780754, 0.07442804425954819, -0.04253949970006943, -0.004523071460425854, 0.09066306054592133, -0.005020082462579012, 0.06197724491357803, 0.11162960529327393, -0.03451555594801903, 0.051346465945243835, 0.06091058999300003, 0.0370173454284668, -0.09576447308063507, 7.21758086445494e-33, -0.054120615124702454, -0.029940923675894737, -0.01800769567489624, -0.0410764105618, -0.07951094210147858, 0.0640573501586914, -0.009362668730318546, 0.022218946367502213, -0.11498069763183594, -0.040375810116529465, -0.22052693367004395, 0.027164675295352936, -0.006474826484918594, 0.0015536770224571228, 0.09805458784103394, -0.09398632496595383, 0.010183189064264297, 0.10732294619083405, -0.0021035950630903244, -0.02380955219268799, -0.0590728297829628, 0.00332530215382576, 0.03865831345319748, 0.00025298004038631916, 0.0013174843043088913, 0.06489604711532593, 0.00699208490550518, -0.04625755548477173, -0.06448155641555786, 0.03830140829086304, -0.00650990754365921, 0.08225321024656296, -0.0774560272693634, -0.02639886736869812, -0.12396074831485748, -0.03977259248495102, -0.1663355529308319, 0.012652621604502201, 0.13275417685508728, 0.002779983915388584, -0.1359681338071823, 0.08786552399396896, -0.11180774867534637, 0.006821880117058754, 0.05144662410020828, 0.02662104181945324, 0.026649493724107742, -0.053164754062891006, -0.05541582405567169, -0.022487230598926544, 0.0005193366669118404, -0.01122106984257698, 0.012610649690032005, -0.01199706457555294, 0.005750665441155434, 0.137724369764328, -0.04355283081531525, -0.07886211574077606, 0.092305988073349, 0.048257507383823395, -0.11731462180614471, 0.24769774079322815, -0.0024856775999069214, -0.07555621862411499, -0.17752531170845032, 0.24838629364967346, -0.013130954466760159, -0.028963036835193634, -0.07447124272584915, 0.08692716062068939, 0.06398172676563263, -0.07664398849010468, 0.06889024376869202, -0.10368314385414124, 0.13139069080352783, 0.007007641717791557, -0.002543102949857712, 0.048894356936216354, 0.1645667850971222, 0.022777872160077095, -0.05911722779273987, 0.00605069100856781, 0.0366368293762207, -0.03447560966014862, 0.05303056538105011, -0.08932701498270035, -0.011930561624467373, 0.03771264851093292, -0.008114119991660118, 0.10513944923877716, 0.047528546303510666, -0.035638101398944855, -0.033478498458862305, 0.228399857878685, 0.030098363757133484, -1.0157999167800273e-32, -0.04462596774101257, -0.07652850449085236, -0.0652427151799202, -0.0012203995138406754, -0.04534725844860077, -0.08879785239696503, 0.01554998941719532, 0.09593082219362259, -0.02422827109694481, -0.07989156991243362, -0.011871177703142166, 0.056576818227767944, -0.03033028356730938, 0.07855191826820374, -0.06674827635288239, -0.016706597059965134, 0.16679686307907104, -0.07844269275665283, -0.01188172772526741, -0.028922248631715775, 0.010143259540200233, 0.16072425246238708, -0.0814293846487999, 0.09078191220760345, 0.12514130771160126, 0.027287563309073448, 0.07206786423921585, 0.0527009591460228, -0.04084425047039986, -0.10773919522762299, -0.07953178137540817, 0.023924248293042183, -0.10147256404161453, 0.16657225787639618, 0.014405722729861736, 0.029482319951057434, 0.016362586989998817, -0.15318691730499268, 0.01954166404902935, 0.017165811732411385, 0.14225295186042786, 0.07060419023036957, 0.0005712676793336868, -0.07662160694599152, 0.08710683882236481, -0.02484023943543434, 0.0740266740322113, 0.03328635171055794, 0.1786409318447113, 0.0697716698050499, 0.06523531675338745, 0.08508899807929993, 0.0014482958940789104, 0.14844724535942078, -0.07305748760700226, 0.04591238498687744, -0.027894096449017525, -0.06693390011787415, -0.12334994971752167, 0.06490497291088104, -0.02684609964489937, 0.1499570608139038, 0.07967972755432129, 0.002522660419344902, 0.014099802821874619, -0.052639275789260864, -0.012174603529274464, -0.12766984105110168, -0.007191729731857777, -0.10220740735530853, 0.1130317822098732, -0.039235640317201614, -0.1276482790708542, -0.09224092960357666, 0.019247237592935562, 0.16708509624004364, -0.033836741000413895, -0.16848167777061462, -0.026439381763339043, -0.10334049165248871, -0.028228066861629486, 0.10833998769521713, 0.019394708797335625, 0.0028275074437260628, -0.10914546251296997, -0.004925280809402466, -0.0019281588029116392, -0.06990291178226471, -0.027605067938566208, -0.01269533857703209, -0.040997106581926346, -0.1509479582309723, -0.08160669356584549, 0.006500186398625374, 0.14162465929985046, -1.0059079613711219e-07, 0.00011229229858145118, -0.03548821806907654, 0.10964556038379669, -0.014771614223718643, 0.1808897852897644, -0.10510051250457764, 0.047957420349121094, 0.015589131973683834, 0.07597079873085022, 0.13424836099147797, 0.18974705040454865, 0.07190865278244019, -0.1458887755870819, 0.14114318788051605, -0.13919830322265625, 0.07730972766876221, -0.07577113807201385, 0.0285345409065485, -0.05194177106022835, -0.11624288558959961, 0.023500097915530205, 0.03685133159160614, 0.04877357929944992, -0.018969621509313583, 0.06453701853752136, -0.18065591156482697, 0.018131865188479424, 0.004326784983277321, -0.10252375155687332, -0.016329454258084297, -0.027839116752147675, -0.04090114310383797, 0.0035413969308137894, 0.026806974783539772, -0.00793471746146679, -0.09822262078523636, 0.07557260245084763, 0.011327536776661873, 0.06448344141244888, 0.03815130144357681, -0.06322016566991806, -0.03440777212381363, 0.11229528486728668, -0.10065943002700806, -0.022087164223194122, -0.08691853284835815, -0.07171587646007538, 0.043959882110357285, 0.019608929753303528, -0.16151395440101624, 0.054926954209804535, -0.04276963695883751, -0.026311838999390602, 0.01823785901069641, 0.12149226665496826, -0.07403764873743057, -0.16719979047775269, -0.0017855046316981316, -0.13485583662986755, -0.006193565204739571, 0.08051582425832748, -0.1637057662010193, 0.04733973741531372, 0.08814708888530731], "changes": {"1wk": 4.224058986637439, "1mo": -3.4894407939474172}}, {"text": "Evolus, Inc. (EOLS) Reports Q3 Loss, Misses Revenue Estimates Zacks Equity Research Thu, Nov 7, 2024, 2:25 AM 3 min read In This Article: EOLS -7.09% Evolus, Inc. (EOLS) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.19 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -137.50%. A quarter ago, it was expected that this company would post a loss of $0.04 per share when it actually produced a loss of $0.07, delivering a surprise of -75%. Over the last four quarters, the company has not been able to surpass consensus EPS estimates. Evolus , which belongs to the Zacks Medical - Products industry, posted revenues of $61.09 million for the quarter ended September 2024, missing the Zacks Consensus Estimate by 2.74%. This compares to year-ago revenues of $50.02 million. The company has topped consensus revenue estimates two times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Evolus shares have added about 56.6% since the beginning of the year versus the S&P 500's gain of 21.2%. What's Next for Evolus? While Evolus has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Evolus: unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.05 on $77.91 million in revenues for the coming quarter and -$0.27 on $266.98 million in revenues for the current fiscal year. Story Continues Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Products is currently in the top 36% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. Apyx Medical (APYX), another stock in the same industry, has yet to report results for the quarter ended September 2024. The results are expected to be released on November 8. This medical device maker is expected to post quarterly loss of $0.15 per share in its upcoming report, which represents a year-over-year change of -15.4%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. Apyx Medical's revenues are expected to be $11.66 million, down 2.7% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Evolus, Inc. (EOLS) : Free Stock Analysis Report Apyx Medical Corporation (APYX) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "EOLS", "date": "2024-11-07T02:25:10", "sentiment": {"score": -0.46815598756074905, "confidence": 0.5469830632209778, "probabilities": {"positive": 0.07882707566022873, "negative": 0.5469830632209778, "neutral": 0.3741898834705353}}, "embedding": [-0.11043597757816315, 0.1023540124297142, -0.08467251062393188, 0.07396329939365387, 0.005535604432225227, -0.05120319873094559, -0.09280954301357269, 0.14992979168891907, 0.24629482626914978, 0.041921261698007584, -0.019952671602368355, 0.09351639449596405, -0.007060968782752752, -0.08924787491559982, -0.0811225026845932, -0.07297159731388092, 0.034020036458969116, -0.05565973371267319, -0.09595461189746857, 0.016900645568966866, 0.006430795881897211, -0.05753633752465248, 0.060896337032318115, -0.0010738493874669075, 0.07933177053928375, 0.017255041748285294, -0.09418080747127533, 0.08611959218978882, -0.13154640793800354, -0.20681828260421753, 0.014176704920828342, 0.06001375615596771, 0.06837286800146103, -0.1526569277048111, -0.053334835916757584, -0.10086477547883987, 0.005389153026044369, 0.05844021961092949, 0.057782307267189026, -0.07953167706727982, -0.06739163398742676, 0.03553352132439613, -0.19436582922935486, -0.043064557015895844, -0.1362796425819397, -0.18423157930374146, 0.04236474633216858, -0.0003049299120903015, 0.0038861706852912903, 0.06335356086492538, -0.11420120298862457, -0.10283401608467102, 0.08696006238460541, -0.02634430304169655, -0.09608016908168793, 0.07570822536945343, -0.11254233121871948, -0.12316761910915375, 0.09259112924337387, 0.0653984397649765, 0.052686657756567, 0.06873483210802078, -0.05223923921585083, 0.14854450523853302, 0.06228157505393028, -0.02755354344844818, 0.14848056435585022, 0.03946686536073685, -0.19882085919380188, 0.1041075587272644, 0.10998110473155975, -0.07648660242557526, -0.05767213553190231, -0.005348260514438152, -0.09650887548923492, 0.12602226436138153, 0.16513288021087646, 0.03829483687877655, 0.09443001449108124, -0.04320283234119415, 0.017007432878017426, -0.060010671615600586, -0.0670291930437088, -0.07864633947610855, -0.010777954012155533, 0.01815599761903286, 0.13538382947444916, 0.05034831911325455, 0.09300531446933746, 0.09962444007396698, 0.03630402684211731, -0.1558254063129425, 0.009572956711053848, -0.025416670367121696, 0.2134815901517868, 0.14668115973472595, -0.03285757452249527, -0.16637878119945526, 0.03411884605884552, 0.07366671413183212, 0.08872826397418976, 0.24926969408988953, -0.006485983729362488, -0.11509693413972855, -0.013078887015581131, -0.056458741426467896, 0.06817135214805603, -0.008779887109994888, 0.04510967433452606, 0.0643928274512291, -0.02651837095618248, -0.012722037732601166, -0.1815582513809204, -0.06815781444311142, -0.03671484440565109, 0.02612505480647087, -0.020274056121706963, 0.15427547693252563, 0.11838839948177338, 0.06166434288024902, 0.12150511145591736, 0.11099536716938019, -0.0520668588578701, 0.07729443907737732, 0.07549542188644409, 0.08422969281673431, -0.10293005406856537, 7.073465257044127e-33, 0.043734997510910034, 0.017168007791042328, -0.04172484949231148, -0.1278228759765625, -0.00822169054299593, 0.08954082429409027, 0.008770911023020744, 0.008988644927740097, 0.026354894042015076, -0.05059901624917984, -0.20965728163719177, 0.1209198608994484, 0.01779085025191307, -0.09967998415231705, 0.040801290422677994, -0.10773144662380219, -0.08472628146409988, 0.12290185689926147, -0.0075662750750780106, 0.01541475672274828, 0.01992996409535408, -0.04629369452595711, 0.08131600171327591, -0.023079873993992805, -0.009482748806476593, 0.13404743373394012, -0.0171896293759346, -0.019063124433159828, -0.14420194923877716, 0.050427138805389404, 0.023808924481272697, 0.08101671934127808, -0.005951456725597382, -0.10172619670629501, -0.04546831175684929, -0.015223033726215363, -0.043486304581165314, -0.033043306320905685, 0.1407344937324524, 0.00397196039557457, -0.09007522463798523, 0.0917009711265564, -0.17440754175186157, -0.1306362748146057, -0.08515378087759018, -0.03081527352333069, 0.04890590161085129, -0.03460937365889549, 0.0024216645397245884, -0.03884868323802948, -0.007359292358160019, 0.016568666324019432, -0.034083522856235504, -0.11608787626028061, -0.0581016018986702, 0.013497940264642239, -0.04247225821018219, -0.056837018579244614, 0.09231546521186829, 0.09424848854541779, 0.023710723966360092, 0.35644030570983887, 0.07689078152179718, -0.08491382002830505, -0.15407738089561462, 0.23498481512069702, -0.0383889377117157, -0.025669636204838753, -0.1794530302286148, 0.1028592586517334, 0.014516550116240978, -0.0753287672996521, 0.10895898938179016, -0.07627449184656143, 0.1899304986000061, -0.027605921030044556, -0.04748860374093056, -0.035019803792238235, 0.15767183899879456, -0.017700733616948128, -0.033272892236709595, -0.053811103105545044, 0.043944329023361206, -0.028419259935617447, 0.09991096705198288, -0.08780971169471741, -0.05389104783535004, 0.16363778710365295, 0.032273389399051666, 0.03723897039890289, 0.11922101676464081, -0.09237398207187653, -0.056963641196489334, 0.20021435618400574, 0.009786589071154594, -9.045717760377423e-33, -0.1434755027294159, 0.04264650493860245, -0.039481960237026215, 0.02244354411959648, -0.048317279666662216, -0.053143419325351715, 0.06722328066825867, 0.1874079406261444, -0.005623508244752884, -0.12119603157043457, -0.07495839893817902, 0.04716045781970024, -0.15977098047733307, 0.064237080514431, 0.014868254773318768, 0.013638698495924473, 0.0811917781829834, -0.1641463339328766, 0.04610712453722954, -0.050440713763237, 0.003752424381673336, 0.20992818474769592, -0.029791144654154778, 0.16296349465847015, 0.12221601605415344, 0.045963969081640244, 0.07072554528713226, 0.08310394734144211, -0.01783756911754608, -0.1506834775209427, 0.05308832973241806, -0.023185191676020622, -0.12069456279277802, 0.09092015027999878, 0.004994426853954792, -0.014008051715791225, -0.047675132751464844, -0.10690174251794815, 0.042885810136795044, -0.05190490931272507, 0.2165372371673584, 0.060630738735198975, 0.03068961203098297, -0.040285974740982056, 0.09715063869953156, 0.05968979373574257, 0.015745703130960464, 0.04367682710289955, 0.20822271704673767, 0.05893329903483391, 0.017099767923355103, 0.04040602594614029, -0.07065390795469284, 0.24172241985797882, -0.07178330421447754, 0.006186354905366898, -0.11417247354984283, -0.017556268721818924, -0.15375758707523346, 0.04942125082015991, -0.04760723561048508, 0.16289392113685608, 0.041839756071567535, 0.06644046306610107, 0.04997246712446213, 0.028328604996204376, -0.030950769782066345, -0.06426160782575607, -0.009394005872309208, -0.08928991854190826, 0.09238229691982269, -0.10127595067024231, -0.0592845119535923, -0.2090694010257721, 0.033975545316934586, 0.28870993852615356, -0.04598250240087509, -0.28043463826179504, -0.07968167215585709, -0.1093938946723938, 0.06144508719444275, 0.1159091517329216, 0.03589330613613129, -0.03438495099544525, -0.13709886372089386, 0.13088858127593994, -0.03384963050484657, -0.05361253023147583, 0.02110755629837513, 0.0037340931594371796, 0.013008416630327702, -0.16442923247814178, -0.11862297356128693, 0.030220435932278633, 0.15726599097251892, -9.965106073650531e-08, 0.029098661616444588, -0.01434009987860918, 0.11979987472295761, -0.012632491067051888, 0.17427605390548706, -0.1457332819700241, 0.05940127372741699, 0.023649925366044044, 0.0861562043428421, 0.07271642982959747, 0.12928473949432373, -0.018899444490671158, -0.097046859562397, 0.05370873957872391, -0.1261780709028244, 0.06945973634719849, -0.03449820727109909, 0.05009208619594574, -0.011950582265853882, -0.12956243753433228, -0.05109121650457382, -0.03707832470536232, 0.06827905029058456, -0.14618057012557983, 0.09000059217214584, -0.15022578835487366, -0.044990088790655136, -0.01911541447043419, -0.04009636864066124, -0.061381593346595764, 0.041749417781829834, -0.024301959201693535, 0.021495789289474487, 0.05597834289073944, -0.05119979754090309, -0.14129188656806946, 0.1082504540681839, 0.01796887069940567, 0.058434151113033295, 0.0011181002482771873, -0.05414297804236412, -0.06876099109649658, 0.0888003557920456, -0.04480999708175659, -0.10322073101997375, -0.0431152880191803, -0.15280559659004211, 0.011274557560682297, -0.02651992440223694, -0.29464107751846313, 0.0769113153219223, -0.09889862686395645, 0.0419415682554245, 0.03450733423233032, 0.10819603502750397, -0.07919040322303772, -0.18546485900878906, -0.03574015572667122, -0.1283186972141266, -0.05931885913014412, 0.15750963985919952, -0.2233770191669464, 0.040738631039857864, 0.11326444149017334], "changes": {"1wk": -27.12670797629169, "1mo": -24.687684416280383}}, {"text": "Here's Why Evolus (EOLS) Could be Great Choice for a Bottom Fisher Zacks Equity Research Mon, Nov 18, 2024, 5:55 PM 3 min read In This Article: EOLS -7.09% The price trend for Evolus, Inc. (EOLS) has been bearish lately and the stock has lost 11.5% over the past week. However, the formation of a hammer chart pattern in its last trading session indicates that the stock could witness a trend reversal soon, as bulls might have gained significant control over the price to help it find support. The formation of a hammer pattern is considered a technical indication of nearing a bottom with likely subsiding of selling pressure. But this is not the only factor that makes a bullish case for the stock. On the fundamental side, strong agreement among Wall Street analysts in raising earnings estimates for this company enhances its prospects of a trend reversal. 1-month candlestick chart for EOLS What is a Hammer Chart and How to Trade It? This is one of the popular price patterns in candlestick charting. A minor difference between the opening and closing prices forms a small candle body, and a higher difference between the low of the day and the open or close forms a long lower wick (or vertical line). The length of the lower wick being at least twice the length of the real body, the candle resembles a 'hammer.' In simple terms, during a downtrend, with bears having absolute control, a stock usually opens lower compared to the previous day's close, and again closes lower. On the day the hammer pattern is formed, maintaining the downtrend, the stock makes a new low. However, after eventually finding support at the low of the day, some amount of buying interest emerges, pushing the stock up to close the session near or slightly above its opening price. When it occurs at the bottom of a downtrend, this pattern signals that the bears might have lost control over the price. And, the success of bulls in stopping the price from falling further indicates a potential trend reversal. Hammer candles can occur on any timeframe -- such as one-minute, daily, weekly -- and are utilized by both short-term as well as long-term investors. Like every technical indicator, the hammer chart pattern has its limitations. Particularly, as the strength of a hammer depends on its placement on the chart, it should always be used in conjunction with other bullish indicators. Here's What Increases the Odds of a Turnaround for EOLS There has been an upward trend in earnings estimate revisions for EOLS lately, which can certainly be considered a bullish indicator on the fundamental side. That's because a positive trend in earnings estimate revisions usually translates into price appreciation in the near term. The consensus EPS estimate for the current year has increased 1.6% over the last 30 days. This means that the Wall Street analysts covering EOLS are majorly in agreement about the company's potential to report better earnings than what they predicted earlier. Story Continues If this is not enough, you should note that EOLS currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises. And stocks carrying a Zacks Rank #1 or 2 usually outperform the market. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Moreover, a Zacks Rank of 2 for Evolus is a more conclusive indication of a potential trend reversal, as the Zacks Rank has proven to be an excellent timing indicator that helps investors identify precisely when a company's prospects are beginning to improve. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Evolus, Inc. (EOLS) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "EOLS", "date": "2024-11-18T17:55:10", "sentiment": {"score": -0.42760080471634865, "confidence": 0.4800930917263031, "probabilities": {"positive": 0.05249228700995445, "negative": 0.4800930917263031, "neutral": 0.4674146771430969}}, "embedding": [-0.09171338379383087, -0.02275085262954235, 0.10301584750413895, 0.029917987063527107, -0.025645118206739426, -0.02584972232580185, -0.05668077617883682, 0.13970331847667694, 0.16118577122688293, 0.06064856797456741, -0.028835903853178024, 0.13282154500484467, -0.08437454700469971, -0.08817362785339355, 0.03845333307981491, -0.018816236406564713, -0.05427280813455582, -0.12692806124687195, -0.08162906765937805, 0.015022656880319118, 0.04397360235452652, -0.17622387409210205, -0.08079008758068085, -0.0345420315861702, -0.0707378089427948, 0.05734658241271973, -0.054196782410144806, 0.11348623037338257, 0.05643875524401665, -0.12485334277153015, 0.04226372763514519, 0.04202331602573395, -0.003240056335926056, -0.0505036786198616, -0.1804162561893463, -0.040927235037088394, 0.04477608576416969, 0.09776720404624939, 0.06386750191450119, 0.00988752394914627, -0.022302793338894844, -0.031401537358760834, -0.12969990074634552, -0.024655066430568695, -0.10641050338745117, 0.0018407697789371014, -0.04103836044669151, 0.014589651487767696, -0.07358496636152267, 0.016987457871437073, -0.025189567357301712, -0.08637505769729614, -0.008321220055222511, 0.04349736124277115, 0.04178018495440483, 0.05739172548055649, -0.019738154485821724, -0.10114312171936035, 0.18667277693748474, 0.029303545132279396, 0.1017221212387085, 0.10960584133863449, -0.1287267655134201, 0.07508061826229095, 0.15416139364242554, -0.015103957615792751, 0.11356015503406525, -0.014379385858774185, -0.04419596493244171, 0.155239999294281, 0.11312069743871689, -0.07797146588563919, -0.08764754235744476, -0.008486309088766575, 0.04703068733215332, 0.09421046823263168, 0.12590157985687256, -0.03250143304467201, 0.037414323538541794, -0.05725236237049103, -0.1221703588962555, 0.008135955780744553, -0.03249404579401016, -0.09329326450824738, -0.01159301120787859, -0.01726648211479187, 0.06948333978652954, -0.06706926971673965, 0.11513738334178925, 0.12778940796852112, 0.0761454775929451, -0.1337723582983017, -0.1401413232088089, 0.05555364489555359, 0.16557949781417847, 0.07349367439746857, 0.01202170830219984, 0.08771859109401703, 0.0276674535125494, 0.09193873405456543, 0.04347743093967438, 0.10101375728845596, -0.021086612716317177, -0.05055370554327965, 0.0048936884850263596, -0.15906323492527008, -0.05991780012845993, 0.012173467315733433, -0.016103290021419525, -0.010798102244734764, -0.09727649390697479, 0.007393502630293369, -0.027642078697681427, -0.0451761931180954, -0.16326932609081268, -0.06463748961687088, -0.07590097188949585, -0.00944914948195219, -0.02395632304251194, -0.029832566156983376, 0.15996664762496948, 0.06218671053647995, -0.09968283772468567, -0.02990386262536049, -0.04025089368224144, 0.061228323727846146, -0.10062998533248901, 4.227167317001196e-33, -0.022278141230344772, -0.07897432148456573, -0.09058338403701782, -0.15973222255706787, -0.04860405623912811, 0.07375917583703995, -0.1187104880809784, 0.026974329724907875, -0.019812321290373802, 0.19509589672088623, 0.01646297611296177, 0.24019747972488403, 0.07304833829402924, 0.07227294147014618, -0.0191846564412117, -0.09335017204284668, 0.042115628719329834, 0.03495078533887863, 0.01846913807094097, -0.12090393155813217, -0.10379819571971893, -0.04767848923802376, 0.014638158492743969, -0.08232070505619049, -0.08727581799030304, 0.07601739466190338, 0.057226892560720444, -0.012306510470807552, -0.12527573108673096, 0.06377074122428894, 0.09486983716487885, 0.04839487373828888, -0.0627252459526062, -0.062468595802783966, 0.0469263419508934, -0.011608310043811798, 0.02593131735920906, -0.12611109018325806, 0.06191873550415039, -0.1324460506439209, -0.07988790422677994, 0.02541668713092804, -0.1932588815689087, -0.017601266503334045, 0.022641519084572792, 0.008468898013234138, 0.001596332062035799, -0.1080319881439209, -0.09953129291534424, -0.018101483583450317, 0.009769236668944359, 0.07948784530162811, 0.08094070851802826, -0.034977786242961884, -0.005195258185267448, 0.04404178261756897, 0.02240717224776745, -0.03899257630109787, -0.049734748899936676, -0.007923712953925133, -0.025561615824699402, 0.18063640594482422, 0.1158546507358551, -0.06011852249503136, -0.07570479065179825, 0.08009310811758041, -0.05002839118242264, 0.0008505970472469926, -0.14654049277305603, 0.06444695591926575, 0.07288805395364761, 0.011831776238977909, 0.01957234926521778, -0.11431995034217834, 0.06725263595581055, 0.007417965680360794, 0.024756059050559998, 0.13331614434719086, 0.009521203115582466, -0.02368323877453804, -0.08750037103891373, -0.10163112729787827, 0.09558625519275665, 0.010287146084010601, 0.002733709290623665, -0.12130916863679886, -0.0631251335144043, -0.061770081520080566, -0.14630986750125885, -0.03966255486011505, -0.030185706913471222, -0.036444902420043945, -0.051110535860061646, 0.19136667251586914, 0.062115952372550964, -7.085363463926357e-33, -0.09587149322032928, 0.03408946841955185, -0.09603612869977951, 0.09148365259170532, 0.01719067618250847, 0.07773979753255844, 0.08122518658638, 0.006680183112621307, -0.057338837534189224, -0.014389360323548317, -0.00928293727338314, 0.04051607474684715, -0.14516866207122803, -0.00086263008415699, 0.03437217324972153, -0.015871819108724594, 0.029948513954877853, 0.038647327572107315, 0.03001115471124649, -0.09463085234165192, 0.06415928900241852, 0.2153465747833252, -0.19266697764396667, 0.09440693259239197, 0.056915849447250366, 0.039671555161476135, 0.007989181205630302, 0.03755548968911171, -0.10823391377925873, -0.08265367895364761, -0.011955475434660912, -0.039429306983947754, -0.008765535429120064, -0.03561415895819664, -0.12156903743743896, 0.08441043645143509, 0.09229277074337006, -0.11436796188354492, 0.023428939282894135, 0.038826391100883484, 0.13290798664093018, 0.11041885614395142, 0.19244852662086487, -0.20109163224697113, 0.0009768716990947723, 0.08738376200199127, 0.06798160076141357, 0.09711791574954987, 0.13836289942264557, 0.14506159722805023, 0.13922716677188873, 0.13961158692836761, -0.04924201965332031, 0.1516016125679016, -0.13000670075416565, 0.026428107172250748, -0.0029007932171225548, -0.06938663870096207, -0.15197871625423431, 0.12415769696235657, -0.04278814047574997, 0.1264163851737976, 0.14314869046211243, 0.002994024194777012, -0.011406496167182922, -0.10501307249069214, 0.011057872325181961, -0.22618712484836578, 0.009224220179021358, -0.12944968044757843, 0.034017786383628845, 0.03639071434736252, 0.012732146307826042, -0.06149665266275406, 0.04199516773223877, 0.09166751801967621, 0.05137283727526665, -0.21485212445259094, -0.051601532846689224, -0.04899711161851883, -0.11605599522590637, 0.05098973214626312, 0.08627769351005554, 0.1589067578315735, -0.12089355289936066, 0.11092718690633774, -0.19779829680919647, 0.047950781881809235, 0.004990566521883011, -0.01705365814268589, 0.04150751978158951, -0.07031351327896118, -0.11492989212274551, -0.013810792937874794, 0.09028979390859604, -9.947252976871823e-08, -0.027479279786348343, -0.06234792247414589, 0.08137167990207672, -0.02085997350513935, 0.11314280331134796, -0.0024965950287878513, 0.16528566181659698, 0.07752853631973267, -0.05230577662587166, 0.06340764462947845, 0.24261023104190826, 0.034043289721012115, -0.07141658663749695, 0.020833853632211685, -0.04941447079181671, -0.0005523134022951126, -0.02624647319316864, -0.05666861683130264, -0.06722702085971832, -0.11019745469093323, 0.014778883196413517, -0.1112859696149826, 0.17201554775238037, 0.02756267599761486, 0.0453835129737854, -0.14268144965171814, 0.020841097459197044, 0.07553451508283615, -0.07261407375335693, 0.02444031834602356, -0.028262518346309662, 0.08803518116474152, 0.07307571917772293, -0.06283102929592133, 0.024765441194176674, 0.10015060007572174, -0.00878850556910038, 0.0044132983312010765, -0.036382801830768585, 0.15619541704654694, -0.07272685319185257, -0.04753582924604416, 0.029298853129148483, -0.014263899065554142, 0.01033344678580761, 0.0403902493417263, -0.010731075890362263, 0.1476690024137497, 0.008193128742277622, -0.07185406237840652, -0.019243324175477028, -0.05900817736983299, 0.08560232818126678, -0.033069416880607605, 0.02631799690425396, -0.03184077516198158, -0.08224126696586609, -0.03496679291129112, 0.059743769466876984, 0.01121965330094099, 0.160654678940773, -0.1619044840335846, -0.07694989442825317, 0.04128531366586685], "changes": {"1wk": 5.671395480872188, "1mo": -7.58965692062932}}, {"text": "Down -29.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Evolus (EOLS) Zacks Equity Research Thu, Nov 14, 2024, 5:35 PM 2 min read In This Article: EOLS -7.09% A downtrend has been apparent in Evolus, Inc. (EOLS) lately with too much selling pressure. The stock has declined 29.8% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround. Here is How to Spot Oversold Stocks We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. Usually, a stock is considered oversold when its RSI reading falls below 30. Technically, every stock oscillates between being overbought and oversold irrespective of the quality of their fundamentals. And the beauty of RSI is that it helps you quickly and easily check if a stock's price is reaching a point of reversal. So, by this measure, if a stock has gotten too far below its fair value just because of unwarranted selling pressure, investors may start looking for entry opportunities in the stock for benefitting from the inevitable rebound. However, like every investing tool, RSI has its limitations, and should not be used alone for making an investment decision. Why a Trend Reversal is Due for EOLS The heavy selling of EOLS shares appears to be in the process of exhausting itself, as indicated by its RSI reading of 25.01. So, the trend for the stock could reverse soon for reaching the old equilibrium of supply and demand. 3-month RSI Chart for EOLS This technical indicator is not the only factor that calls for a potential rebound for the stock. There is a fundamental indicator as well. A strong agreement among sell-side analysts covering EOLS in raising earnings estimates for the current year has led to an increase in the consensus EPS estimate by 1.6% over the last 30 days. And an upward trend in earnings estimate revisions usually translates into price appreciation in the near term. Moreover, EOLS currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises. This is a more conclusive indication of the stock's potential turnaround in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Story Continues Evolus, Inc. (EOLS) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "EOLS", "date": "2024-11-14T17:35:06", "sentiment": {"score": -0.28141574561595917, "confidence": 0.42347487807273865, "probabilities": {"positive": 0.14205913245677948, "negative": 0.42347487807273865, "neutral": 0.43446606397628784}}, "embedding": [-0.08752918243408203, -0.051489293575286865, 0.0762249156832695, 0.08217163383960724, 0.025539454072713852, -0.0379066988825798, -0.08148635923862457, 0.14042413234710693, 0.13188289105892181, 0.05849427729845047, -0.09112434089183807, 0.10626506060361862, -0.06649418920278549, -0.0962400734424591, 0.06155754253268242, -0.11041818559169769, 0.00018993020057678223, -0.06829530745744705, -0.1677543818950653, 0.01735764369368553, -0.0312286838889122, -0.1478743553161621, -0.08940692245960236, -0.039496030658483505, -0.03910428285598755, 0.026416106149554253, -0.04604744166135788, 0.04526478052139282, -0.10348956286907196, -0.10996945947408676, -0.033232204616069794, 0.07128291577100754, 0.06184875965118408, -0.015394896268844604, -0.13688534498214722, -0.025552362203598022, -0.01481427252292633, 0.0477580726146698, 0.13061560690402985, -0.008930357173085213, -0.04340440779924393, 0.0014622402377426624, -0.1547190248966217, -0.07978177070617676, -0.009335868060588837, -0.1437256932258606, -0.06970081478357315, 0.03534580394625664, 0.010637928731739521, -0.028088318184018135, -0.13270419836044312, -0.04488355666399002, 0.041754867881536484, 0.02180572599172592, -0.044532615691423416, 0.0331946425139904, 0.03079104609787464, -0.09568610042333603, 0.1098344475030899, 0.015810150653123856, 0.16065749526023865, 0.013540040701627731, -0.0429711751639843, 0.01760389469563961, 0.1562575399875641, 0.029509328305721283, 0.09294501692056656, 0.009898118674755096, -0.03180287778377533, 0.21062523126602173, 0.07965708523988724, -0.07526759803295135, -0.10876228660345078, -0.03387511894106865, 0.030106406658887863, 0.04696822166442871, 0.001461721956729889, -0.04526861757040024, 0.011678129434585571, -0.11634986102581024, 0.03268374502658844, -0.029812850058078766, -0.03976400941610336, -0.16001500189304352, 0.002978811040520668, -0.021216508001089096, 0.12349088490009308, -0.04593116417527199, 0.13654717803001404, 0.07155890762805939, 0.15674073994159698, -0.10742375254631042, -0.09968414902687073, 0.05669493228197098, 0.2593597173690796, 0.06298895925283432, -0.051890596747398376, -0.018369119614362717, -0.09477443993091583, 0.08749231696128845, 0.03748946636915207, 0.19638481736183167, -0.07083417475223541, -0.005841484759002924, -0.015294341370463371, -0.09274903684854507, 0.023158177733421326, -0.03976735472679138, -0.047442477196455, -0.03079947456717491, -0.06841146945953369, 0.03010314330458641, -0.030328568071126938, -0.08883947134017944, -0.024201342836022377, 0.07379256933927536, 0.017278067767620087, 0.08006405830383301, -0.05158242583274841, 0.01504540629684925, 0.09006598591804504, 0.09901413321495056, -0.14219024777412415, 0.03217341750860214, 0.07041035592556, 0.07699655741453171, -0.1828906536102295, 1.132876288854447e-32, 0.052687883377075195, 0.02108662575483322, -0.07054153084754944, -0.10366205871105194, -0.10303162038326263, -0.05489155277609825, -0.012674900703132153, -0.04248226433992386, 0.007016591262072325, 0.04555130749940872, -0.04337117448449135, 0.16708287596702576, -0.00495387427508831, -0.03594942390918732, 0.01638120599091053, -0.12921778857707977, 0.012316800653934479, 0.08270777761936188, 0.05390783026814461, -0.059359028935432434, -0.018897755071520805, -0.146100252866745, -0.0829257220029831, -0.13945552706718445, -0.04715970531105995, -0.061640664935112, 0.0020925835706293583, 0.06388892233371735, -0.12718641757965088, 0.03926683962345123, 0.08233708143234253, 0.0324842594563961, -0.06527092307806015, -0.038706351071596146, -0.005917642265558243, -0.16088789701461792, -0.020474623888731003, -0.008149784058332443, 0.13821271061897278, -0.006943054497241974, -0.10427641123533249, 0.13693341612815857, -0.1792183816432953, -0.05537170544266701, 0.09228841960430145, -0.01917252130806446, 0.0016550071304664016, -0.123375803232193, -0.06195884197950363, 0.012883593328297138, 0.008400151506066322, 0.037909094244241714, -0.02246052213013172, -0.014613727107644081, -0.1175559014081955, 0.08069518208503723, 0.09097106754779816, -0.04347171261906624, 0.06108466163277626, 0.07246547192335129, 0.036321014165878296, 0.13051846623420715, 0.037989288568496704, -0.0754958838224411, -0.164225772023201, 0.18175241351127625, -0.035148974508047104, 0.03257065638899803, -0.18864810466766357, 0.14038445055484772, -0.05247630923986435, -0.030064836144447327, 0.09059509634971619, -0.0597122386097908, 0.1162915974855423, -0.04813416302204132, -0.013483861461281776, 0.036652155220508575, 0.06601858139038086, -0.04694034531712532, -0.0184294693171978, -0.033105939626693726, 0.09386561810970306, -0.0407227985560894, 0.039760760962963104, -0.09428782761096954, -0.07312990725040436, -0.07209296524524689, -0.08772918581962585, -0.06792004406452179, 0.07144045829772949, -0.02679545246064663, -0.013235487975180149, 0.1790170967578888, 0.03327150270342827, -1.1915420527629195e-32, -0.08162912726402283, -0.03479284793138504, -0.11484394967556, 0.05247955024242401, -0.0929073691368103, -0.012669066898524761, 0.03538823127746582, 0.09461819380521774, -0.06325268745422363, -0.05818220227956772, -0.01557188294827938, 0.0007096943445503712, -0.051277901977300644, -0.01894518919289112, 0.03465801477432251, 0.020413346588611603, 0.10869671404361725, -0.03681652992963791, 0.0031355232931673527, -0.06872760504484177, -0.017137382179498672, 0.13133913278579712, -0.01069886889308691, 0.07631509006023407, 0.05845902860164642, 0.10851311683654785, 0.0485059879720211, 0.1337101012468338, 0.004895085468888283, -0.16886118054389954, -0.014439982362091541, -0.054052770137786865, -0.053322531282901764, 0.12898726761341095, -0.04171426594257355, 0.06425422430038452, -0.034040626138448715, -0.1316552609205246, 0.022433435544371605, 0.055293008685112, 0.11835800111293793, 0.18897268176078796, 0.17427659034729004, -0.0024054106324911118, 0.02669014222919941, 0.016366783529520035, 0.11231864988803864, 0.09523036330938339, 0.16234859824180603, 0.006424684077501297, 0.10512541234493256, 0.03848063200712204, 0.05837780237197876, 0.20207417011260986, -0.012022623792290688, 0.068597212433815, 0.00029058102518320084, -0.01694738306105137, -0.13958017528057098, 0.1308610737323761, 0.011977320536971092, 0.15571799874305725, 0.07428424060344696, -0.04586533457040787, 0.026316236704587936, -0.03817363828420639, -0.0042617786675691605, -0.18847858905792236, 0.13041353225708008, -0.06495996564626694, 0.08613601326942444, -0.07310840487480164, -0.0596063993871212, -0.11320099234580994, 0.010120125487446785, 0.16004469990730286, -0.06988586485385895, -0.07528868317604065, -0.053984783589839935, -0.0364861860871315, -0.13155347108840942, 0.0777922049164772, -0.007007311098277569, 0.03489237278699875, -0.09241963177919388, 0.0813794732093811, -0.15522754192352295, 0.04141135886311531, 0.06724707037210464, -0.017638355493545532, 0.05695079267024994, -0.12130782008171082, -0.09317494928836823, 0.04762822762131691, 0.07738643139600754, -9.985825499825296e-08, 0.032076213508844376, -0.16644391417503357, 0.0792798101902008, -0.03946198150515556, 0.18273699283599854, -0.09957063943147659, 0.14026138186454773, -0.026918675750494003, 0.027312660589814186, 0.04704651981592178, 0.2072630226612091, -0.06349580734968185, -0.12427639216184616, 0.0040083713829517365, -0.06251905113458633, -0.0475449413061142, -0.10292650759220123, 0.06573053449392319, -0.05298114940524101, -0.06381018459796906, 0.050934698432683945, -0.10636473447084427, 0.12341326475143433, 0.0646035373210907, 0.07946833968162537, -0.05723853409290314, -0.002268316224217415, 0.0008552093058824539, -0.053389985114336014, -0.024463633075356483, 0.025640100240707397, 0.0108829066157341, 0.14379996061325073, 0.036400359123945236, 0.05646331608295441, 0.11850279569625854, 0.10259151458740234, 0.03796639293432236, -0.0017370108980685472, 0.21174174547195435, -0.03819228708744049, -0.07887904345989227, 0.007963059470057487, -0.000761672854423523, 0.05622115731239319, -0.01270185224711895, -0.08932329714298248, 0.06786984205245972, 0.03159547969698906, -0.27169060707092285, -0.018504660576581955, -0.05646864324808121, 0.04108816385269165, 0.11793294548988342, -0.03051416203379631, 0.03147679194808006, -0.23581476509571075, 0.043240513652563095, -0.11688713729381561, 0.07260899990797043, 0.07923378795385361, -0.19238057732582092, -0.1146586686372757, 0.09364130347967148], "changes": {"1wk": 9.764308385839607, "1mo": -3.114477121168736}}, {"text": "Earnings Update: Evolus, Inc. (NASDAQ:EOLS) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts editorial-team@simplywallst.com (Simply Wall St) Sat, Nov 9, 2024, 5:23 PM 3 min de lectura En este art\u00edculo: EOLS -7.09% The analysts might have been a bit too bullish on Evolus, Inc. ( NASDAQ:EOLS ), given that the company fell short of expectations when it released its quarterly results last week. It was a pretty negative result overall, with revenues of US$61m missing analyst predictions by 3.7%. Worse, the business reported a statutory loss of US$0.30 per share, much larger than the analysts had forecast prior to the result. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Evolus after the latest results. See our latest analysis for Evolus NasdaqGM:EOLS Earnings and Revenue Growth November 9th 2024 Taking into account the latest results, the consensus forecast from Evolus' six analysts is for revenues of US$348.6m in 2025. This reflects a major 40% improvement in revenue compared to the last 12 months. The loss per share is expected to greatly reduce in the near future, narrowing 58% to US$0.37. Before this latest report, the consensus had been expecting revenues of US$350.9m and US$0.32 per share in losses. While next year's revenue estimates held steady, there was also a considerable increase in loss per share expectations, suggesting the consensus has a bit of a mixed view on the stock. The consensus price target held steady at US$23.43, seemingly implying that the higher forecast losses are not expected to have a long term impact on the company's valuation. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. There are some variant perceptions on Evolus, with the most bullish analyst valuing it at US$27.00 and the most bearish at US$20.00 per share. With such a narrow range of valuations, the analysts apparently share similar views on what they think the business is worth. Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. The period to the end of 2025 brings more of the same, according to the analysts, with revenue forecast to display 31% growth on an annualised basis. That is in line with its 37% annual growth over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenues grow 10% per year. So it's pretty clear that Evolus is forecast to grow substantially faster than its industry. La historia contin\u00faa The Bottom Line The most important thing to note is the forecast of increased losses next year, suggesting all may not be well at Evolus. Happily, there were no major changes to revenue forecasts, with the business still expected to grow faster than the wider industry. The consensus price target held steady at US$23.43, with the latest estimates not enough to have an impact on their price targets. With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have forecasts for Evolus going out to 2026, and you can see them free on our platform here. Before you take the next step you should know about the 2 warning signs for Evolus that we have uncovered. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Ver comentarios Condiciones y Pol\u00edtica de privacidad Privacy Dashboard Historias recomendadas", "symbol": "EOLS", "date": "2024-11-09T17:23:24", "sentiment": {"score": -0.9019225835800171, "confidence": 0.9357077479362488, "probabilities": {"positive": 0.03378516435623169, "negative": 0.9357077479362488, "neutral": 0.030507002025842667}}, "embedding": [-0.035558171570301056, -0.006128797307610512, -0.03618249669671059, 0.09121137112379074, -0.008878134191036224, 0.004895718768239021, -0.06280484795570374, 0.15139684081077576, 0.1306317299604416, 0.007802693173289299, -0.08497543632984161, 0.0935998260974884, 0.018205666914582253, -0.08043944090604782, -0.07081158459186554, -0.04245363920927048, -0.00021919980645179749, -0.0638953149318695, -0.10793599486351013, -0.007156664505600929, -0.051166146993637085, -0.02665068209171295, -0.09274481981992722, -0.04684610664844513, 0.11557474732398987, 0.0039766342379152775, -0.08503171801567078, 0.002463230863213539, -0.12535922229290009, -0.1696988046169281, -0.027269721031188965, 0.04259684681892395, 0.08111388981342316, -0.11063213646411896, -0.09324102103710175, -0.1324673593044281, -0.022245224565267563, 0.026777343824505806, 0.09790292382240295, -0.04784468933939934, 0.008309454657137394, 0.04321214556694031, -0.11504030227661133, -0.002832585945725441, -0.11362235248088837, -0.13815203309059143, 0.031768642365932465, -0.030889499932527542, -0.03546532616019249, 0.0416247621178627, -0.13788951933383942, -0.0663997009396553, 0.047850675880908966, -0.08739915490150452, -0.0477532222867012, 0.03824734687805176, -0.0991610735654831, -0.09644356369972229, 0.09096352010965347, -0.005094481632113457, -0.048747144639492035, 0.08976982533931732, -0.006114185322076082, 0.09907719492912292, 0.19000807404518127, -0.03633056581020355, 0.09740172326564789, 0.0690765231847763, -0.2132250815629959, 0.12365379184484482, 0.07259422540664673, -0.0915628969669342, -0.04611843824386597, -0.08123696595430374, -0.03198016807436943, 0.177006334066391, 0.14170649647712708, 0.04715618118643761, 0.09221232682466507, -0.07339350879192352, 0.0026033613830804825, -0.048451393842697144, -0.1547093242406845, -0.16238021850585938, -0.06483135372400284, -0.03394147753715515, 0.1371919810771942, -0.019414793699979782, 0.08276791125535965, 0.025148827582597733, 0.1533617377281189, -0.08496826887130737, -0.03483111411333084, 0.032863549888134, 0.2577947676181793, 0.1801953762769699, -0.06714940816164017, -0.14957702159881592, 0.0073481048457324505, 0.10785943269729614, 0.11085130274295807, 0.22340819239616394, 0.03229839727282524, -0.12004457414150238, -0.09940406680107117, -0.10866507887840271, 0.07756452262401581, -0.041378483176231384, -0.04339044541120529, 0.03880690038204193, -0.051625125110149384, 0.0015453370288014412, -0.11422968655824661, -0.10177578777074814, -0.033341437578201294, 0.024081502109766006, 0.004872125573456287, 0.10107255727052689, 0.05066166818141937, -0.04231521487236023, 0.055124957114458084, 0.1239599734544754, 0.0708291083574295, 0.12508121132850647, 0.09098739922046661, 0.031185410916805267, -0.14104291796684265, 9.922788625672487e-33, -0.02109117992222309, -0.030312765389680862, -0.03564111143350601, -0.19410666823387146, -0.03725208714604378, 0.09101434051990509, 0.007344583980739117, 0.037329524755477905, -0.014707401394844055, -0.039416663348674774, -0.1431901454925537, 0.13385123014450073, 0.02726060152053833, -0.004417072050273418, 0.03227654844522476, -0.10664641857147217, 0.05410696938633919, 0.0863053947687149, -0.05016853287816048, 0.03468523919582367, 0.04316534847021103, 0.035018667578697205, 0.029761146754026413, -0.03346258029341698, -0.005484192166477442, 0.039493221789598465, 0.03740912675857544, -0.007291857153177261, -0.12338443845510483, 0.05114142224192619, -0.014082159847021103, 0.121344655752182, -0.03956970199942589, -0.009091116487979889, -0.009404825046658516, -0.07860259711742401, -0.11761186271905899, 0.05048474296927452, 0.09367651492357254, -0.03381793946027756, -0.06157989427447319, 0.06516323238611221, -0.11086063086986542, -0.11833490431308746, -0.0014218026772141457, 0.04140191525220871, 0.04607416316866875, -0.0686914473772049, -0.048538051545619965, -0.07960803061723709, -0.021897107362747192, -0.01915709115564823, -0.06488746404647827, -0.028172481805086136, -0.002678744262084365, 0.06561169028282166, -0.055246610194444656, -0.03365165740251541, 0.10157252848148346, -0.0014006011188030243, -0.03939634934067726, 0.3075430691242218, 0.07201352715492249, -0.12006612122058868, -0.19819441437721252, 0.2488844394683838, -0.021445706486701965, 0.08182241022586823, -0.0884745642542839, 0.05251214653253555, 0.03212345391511917, -0.09197303652763367, 0.07957617193460464, 0.0009031947702169418, 0.12787404656410217, 0.012428730726242065, -0.04511207714676857, 0.025734873488545418, 0.14521479606628418, -0.05058418959379196, -0.00031025148928165436, 0.03109964355826378, 0.09815260022878647, -0.07198876142501831, 0.10739832371473312, -0.07048007845878601, -0.007616179063916206, 0.15375903248786926, 0.030912891030311584, 0.08596207201480865, 0.06266128271818161, -0.032017696648836136, -0.07012881338596344, 0.18221355974674225, 0.032751746475696564, -1.1947660664252404e-32, -0.13375741243362427, 0.027171004563570023, -0.08599898964166641, 0.007729888428002596, -0.08540602028369904, -0.1146172434091568, 0.09728969633579254, 0.15545564889907837, -0.01614510267972946, -0.09633510559797287, -0.029509287327528, 0.010009035468101501, -0.06902697682380676, 0.028784966096282005, 0.0326070711016655, -0.02414628490805626, 0.12036487460136414, -0.1585569679737091, 0.000984756974503398, -0.03697462007403374, 0.012227113358676434, 0.15860047936439514, -0.09511100500822067, 0.14312481880187988, 0.11672092974185944, 0.05246417596936226, 0.13160628080368042, 0.06489391624927521, -0.08944317698478699, -0.17017164826393127, -0.029857829213142395, -0.003909316845238209, -0.15014082193374634, 0.14559714496135712, 0.023216018453240395, -0.006367050111293793, 0.04258384183049202, -0.1354411244392395, -0.053421735763549805, -0.03526235371828079, 0.09147153794765472, 0.09673812240362167, 0.022031938657164574, -0.05849415063858032, 0.11874111741781235, 0.07406887412071228, 0.06640942394733429, 0.013678979128599167, 0.1438201367855072, 0.06368093937635422, 0.05427906662225723, 0.034799471497535706, -0.044958535581827164, 0.15074865520000458, -0.060744255781173706, -0.029602795839309692, 0.03108963929116726, -0.054551273584365845, -0.047148723155260086, 0.0991215631365776, -0.04285016655921936, 0.12506431341171265, 0.08099986612796783, -0.060053564608097076, 0.009738210588693619, -0.008525505661964417, -0.04220159351825714, -0.10726659744977951, 0.04185233637690544, -0.10421940684318542, 0.09263835847377777, -0.1557125449180603, -0.16033901274204254, -0.12372320145368576, 0.038617201149463654, 0.25270578265190125, -0.01719750091433525, -0.16173824667930603, -0.007692432962357998, -0.01788954995572567, -0.015677006915211678, 0.1135944277048111, 0.06930775195360184, -0.007669111248105764, -0.016070716083049774, 0.06465350836515427, -0.03464370220899582, -0.07794256508350372, 0.013422775082290173, 0.03178422525525093, -0.06402647495269775, -0.13682404160499573, -0.09113137423992157, 0.043829478323459625, 0.12209060788154602, -1.002015466156081e-07, -0.044618502259254456, -0.03783102333545685, 0.10402920097112656, 0.028173984959721565, 0.1542990803718567, -0.18033242225646973, 0.04627632349729538, 0.01465550996363163, 0.022434061393141747, 0.09755771607160568, 0.19040411710739136, -0.09087647497653961, -0.16059769690036774, 0.09235608577728271, -0.08143097162246704, 0.05019925907254219, -0.050467003136873245, -0.020971884950995445, -0.009121324867010117, -0.11625057458877563, 0.062139928340911865, 0.007135691121220589, 0.02882356010377407, -0.06312814354896545, 0.11509551107883453, -0.1760600507259369, -0.043403834104537964, 0.03488444164395332, -0.09543861448764801, -0.01192965917289257, -0.00019661430269479752, -0.0031585991382598877, 0.02249636873602867, -0.046571046113967896, -0.044481828808784485, -0.04714854806661606, 0.1325882375240326, 0.052172232419252396, 0.07162503898143768, 0.09293797612190247, -0.0485321506857872, -0.09875864535570145, 0.14323604106903076, -0.07151816785335541, -0.08527151495218277, -0.07240917533636093, -0.1045137345790863, 0.02434680238366127, 0.028548285365104675, -0.21141491830348969, 0.06569813191890717, -0.10939803719520569, 0.03108731098473072, 0.08750259876251221, 0.1825903058052063, -0.13460923731327057, -0.15313154458999634, -0.07009623944759369, -0.11565885692834854, -0.004869044758379459, 0.09312298893928528, -0.2489844560623169, -0.01738458126783371, 0.10270555317401886], "changes": {"1wk": -7.6981725433818236, "1mo": -3.506097882312372}}, {"text": "Evolus Inc (EOLS) Q3 2024 Earnings Call Highlights: Revenue Surge Amid Market Challenges GuruFocus News Thu, Nov 7, 2024, 2:00 PM 4 min read In This Article: EOLS -7.09% Net Revenue: $61.1 million for Q3 2024, a 22% increase compared to Q3 2023. Gross Margin: Reported at 68.9%; adjusted gross margin at 70.2%. Operating Expenses: GAAP operating expenses were $76.6 million; non-GAAP operating expenses were $49.6 million. SG&A Expenses: $52.5 million, including $5.2 million of noncash stock-based compensation. Non-GAAP Operating Loss: $6.7 million for Q3 2024. Cash Position: Ended Q3 2024 with $85 million in cash, down from $93.7 million at June 30, 2024. Cash Burn: $8.7 million in Q3 2024. 2024 Revenue Guidance: Narrowed to $260 million to $266 million, representing 29% to 32% growth year-over-year. Adjusted Gross Profit Margin Guidance: 68% to 71% for 2024. Non-GAAP Operating Expenses Guidance: Between $185 million and $190 million for 2024. Warning! GuruFocus has detected 5 Warning Sign with EOLS. Release Date: November 06, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript . Positive Points Evolus Inc ( NASDAQ:EOLS ) achieved a 22% increase in net revenue for the third quarter, reaching $61 million, which is significantly above market growth. The company successfully expanded its product portfolio with the approval of Estyme in Europe, positioning itself as one of only five companies globally offering a portfolio of injectable aesthetic products. Evolus Inc ( NASDAQ:EOLS ) added over 600 purchasing accounts in the third quarter and maintained a strong reorder rate of over 70%. The Evolus Rewards program surpassed 1 million consumers enrolled, demonstrating strong consumer engagement and loyalty. The company is on track to launch Evolysse in the U.S. by September 2025, with expectations of further market expansion and operating margin growth. Negative Points Evolus Inc ( NASDAQ:EOLS ) reported a non-GAAP operating loss of $6.7 million in the third quarter, compared to a non-GAAP operating income of $1.1 million in the second quarter. The company's cash position decreased from $93.7 million at the end of June 2024 to $85 million at the end of the third quarter. There is a noted softness in the filler market, which could impact the launch and performance of Evolysse. The company anticipates that profitability may not be sustained every quarter in 2025 due to the launch of Evolysse. Evolus Inc ( NASDAQ:EOLS ) narrowed its total net revenue guidance range, indicating potential caution or uncertainty in achieving the upper end of its previous forecast. Q & A Highlights Q : Can you explain how Evolysse will be launched using your digital platform and how it compares to your toxin product strategy? A : David Moatazedi, CEO, explained that Evolysse will leverage the existing digital platform, including the Evolus app and Evolus Rewards program. The platform will support pricing strategies and consumer loyalty, although specific pricing details were not disclosed. The cash-pay model allows for unique co-branded media opportunities, unlike competitors with therapeutic links. Story Continues Q : Why did you narrow the guidance range for 2024, and is there any concern about meeting targets? A : Sandra Beaver, CFO, clarified that narrowing the guidance is typical as the year progresses and not indicative of any concerns. The company remains confident in achieving the revised guidance, reflecting better visibility with only one quarter remaining. Q : What are the current trends in the toxin market, and how are your marketing efforts performing? A : David Moatazedi, CEO, noted that the toxin market remains resilient with typical seasonal trends. Evolus continues to see growth and strong consumer engagement, with the fourth quarter expected to be the strongest due to holiday season demand. Q : How are recent pricing trends and market share for Jeuveau, and what is the outlook for 2025? A : Sandra Beaver, CFO, reported stable pricing trends with potential slight increases and a market share of around 13%. The company expects continued growth in the toxin market, projecting mid- to high single-digit growth rates. Q : How does the decline in JUVEDERM sales affect your filler launch strategy? A : David Moatazedi, CEO, acknowledged the softness in the filler market but emphasized the significant opportunity due to the large market size. Evolysse's differentiated cold HA technology is expected to attract interest, and the company remains optimistic about its growth potential. For the complete transcript of the earnings call, please refer to the full earnings call transcript . This article first appeared on GuruFocus . View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "EOLS", "date": "2024-11-07T14:00:46", "sentiment": {"score": 0.8138482496142387, "confidence": 0.8843643665313721, "probabilities": {"positive": 0.8843643665313721, "negative": 0.07051611691713333, "neutral": 0.045119594782590866}}, "embedding": [-0.06153422221541405, 0.028742749243974686, -0.08167386054992676, -0.040469344705343246, -0.08041086792945862, 0.0028268343303352594, 0.036942485719919205, 0.11698780953884125, 0.1887572705745697, 0.055431731045246124, 0.050686098635196686, 0.021340174600481987, 0.0031039565801620483, -0.03691208362579346, 0.013419879600405693, -0.031865403056144714, 0.04853187873959541, -0.06133616343140602, -0.014305302873253822, -0.03548311069607735, 0.08217351138591766, -0.10511545091867447, -0.03978049010038376, -0.10217516869306564, 0.11864912509918213, -0.04432648420333862, -0.05143382400274277, 0.11788047850131989, -0.0926886722445488, -0.20370075106620789, 0.03380633890628815, -0.007589656859636307, 0.061274610459804535, -0.10841293632984161, 0.01588059961795807, 0.003750870004296303, -0.10701189935207367, -0.023945994675159454, -0.0809614360332489, -0.11450021713972092, -0.08239705860614777, -0.019405238330364227, -0.21120133996009827, -0.03601519390940666, 0.014663134701550007, -0.15650221705436707, -0.04192790761590004, 0.07061508297920227, 0.027972403913736343, -0.037094615399837494, -0.03706447035074234, -0.08805795758962631, 0.06900312006473541, -0.0021268771961331367, -0.06763824075460434, 0.03281828388571739, -0.06428912281990051, -0.0712021067738533, -0.004334889817982912, 0.0051167793571949005, 0.02384898066520691, 0.00019787298515439034, -0.07260803878307343, 0.1138128936290741, 0.09375923126935959, 0.034835174679756165, 0.04276764392852783, -0.02390807494521141, -0.20253846049308777, 0.058231864124536514, -0.029087629169225693, -0.18093577027320862, -0.06133697181940079, -0.04560218006372452, -0.010580078698694706, 0.2582623362541199, 0.13675805926322937, 0.09433335065841675, 0.06639950722455978, -0.09324946999549866, 0.04994462430477142, -0.0012215152382850647, -0.099500872194767, -0.061173904687166214, -0.03671110048890114, -0.0065124318934977055, 0.06541837751865387, 0.03215120732784271, 0.1454152762889862, 0.07534337043762207, 0.11383762955665588, -0.06722423434257507, -0.03900693356990814, -0.026565728709101677, 0.14082731306552887, 0.03431902825832367, -0.07881714403629303, -0.1056344136595726, -0.001560051692649722, 0.05890995264053345, 0.11081412434577942, 0.21751239895820618, -0.028491297736763954, -0.11645356565713882, -0.05327219143509865, 0.006983994040638208, 0.0734996348619461, 0.047840483486652374, 0.007148455828428268, -0.07128944993019104, -0.13046687841415405, 0.04131283238530159, -0.10447976738214493, -0.1112947165966034, -0.05034300684928894, 0.1820005625486374, -0.07171770930290222, 0.16376665234565735, 0.17980509996414185, -0.06431590765714645, 0.11899983882904053, 0.0839059129357338, -0.06947515904903412, 0.06632483005523682, -0.08214441686868668, 0.04964517056941986, -0.0881035178899765, 1.6812240527670955e-32, -0.03536103665828705, 0.00011781124339904636, 0.02907627448439598, -0.1448386162519455, 0.031461410224437714, 0.10409481823444366, 0.035511039197444916, 0.047451168298721313, -0.16264934837818146, 0.005487607792019844, -0.12015385925769806, 0.1060929149389267, 0.03613942861557007, -0.019551094621419907, 0.11872163414955139, -0.12028519809246063, -0.14396879076957703, 0.06035303324460983, 0.0470522865653038, -0.009676853194832802, 0.022253280505537987, -0.05524018406867981, 0.013261944986879826, 0.010478914715349674, 0.05626475438475609, 0.14565473794937134, -0.00171747338026762, -0.02778494358062744, -0.0751991719007492, 0.05757300183176994, -0.02661193162202835, 0.0506918802857399, -0.049558430910110474, -0.11844877153635025, -0.026334961876273155, 0.05262790620326996, -0.06112849712371826, -0.07134141027927399, 0.12432403862476349, -0.0448707640171051, -0.04577529802918434, 0.08615800738334656, -0.05726815015077591, -0.14106833934783936, -0.11032474040985107, -0.03694272041320801, 0.12775541841983795, -0.05044665187597275, 0.05002332478761673, 0.020144877955317497, -0.01425038930028677, 0.004559792578220367, -0.03216632455587387, -0.05110020563006401, 0.004939906299114227, 0.0389738529920578, 0.0322076752781868, 0.06213834881782532, 0.093696728348732, 0.09259293973445892, -0.08382263779640198, 0.14489883184432983, -0.05467354133725166, -0.05662944167852402, -0.21301189064979553, 0.220351904630661, 0.034712307155132294, -0.04624321311712265, -0.08211704343557358, 0.13572059571743011, 0.014729136601090431, -0.10523507744073868, 0.14362066984176636, -0.0471545085310936, 0.15347807109355927, -0.01382264494895935, -0.09270474314689636, 0.03296664357185364, 0.1205192357301712, -0.014229799620807171, -0.08261657506227493, -0.021292738616466522, 0.026449427008628845, -0.07657693326473236, 0.05977503955364227, -0.08098531514406204, -0.04917173832654953, 0.08845162391662598, -0.0171817634254694, 0.055725861340761185, 0.10636688023805618, 0.0213240385055542, -0.0005149664357304573, 0.2337387502193451, -0.051864754408597946, -1.5569553450387727e-32, -0.08671112358570099, -0.007496543228626251, -0.06877554208040237, -0.05970640107989311, -0.049570418894290924, -0.024346336722373962, 0.1054232120513916, 0.09380725026130676, -0.013247359544038773, -0.08663251250982285, -0.0307463426142931, 0.11098401248455048, -0.0751572698354721, 0.027815867215394974, -0.011197865009307861, -0.004013488534837961, -0.00883493572473526, -0.06006108969449997, 0.02042517252266407, -0.014168852008879185, 0.10880544781684875, 0.2885361909866333, 0.01279895007610321, 0.1124952882528305, 0.12990239262580872, 0.08211659640073776, 0.09264545887708664, 0.08830627053976059, -0.037560977041721344, -0.09583300352096558, 0.02100526914000511, -0.035582102835178375, -0.15687404572963715, 0.10436862707138062, 0.020120859146118164, -0.05458233878016472, 0.04907089099287987, -0.10996706783771515, 0.03486958518624306, -0.022266753017902374, 0.19762751460075378, 0.12293601036071777, 0.024481359869241714, -0.0271315835416317, 0.06841983646154404, 0.05388033390045166, 0.013229154981672764, -0.05397661402821541, 0.16111937165260315, 0.06593649089336395, -0.08144435286521912, 0.02353302575647831, -0.016139322891831398, 0.216537743806839, -0.11005966365337372, 0.0030711516737937927, -0.021863266825675964, -0.024539731442928314, -0.08578692376613617, 0.021684400737285614, -0.0592191219329834, 0.15782655775547028, 0.1135919839143753, 0.0024975230917334557, 0.08779938519001007, 0.019018862396478653, 0.0343056246638298, -0.03544418513774872, -0.031734198331832886, -0.19282230734825134, -0.02983548864722252, -0.049502357840538025, -0.09177753329277039, -0.21524754166603088, -0.06322981417179108, 0.19665373861789703, -0.042306602001190186, -0.09583424031734467, -0.0407557338476181, -0.15259814262390137, 0.017867207527160645, 0.06727920472621918, 0.00010298565030097961, 0.05049995332956314, -0.014412470161914825, 0.08588884025812149, -0.08752651512622833, -0.07254514843225479, 0.021080559119582176, 0.0832354724407196, -0.006037261337041855, -0.0397442951798439, 0.04102163761854172, 0.15885663032531738, 0.12065557390451431, -9.963511615751486e-08, 0.031060386449098587, 0.031889550387859344, 0.10289229452610016, -0.03335738182067871, 0.17565971612930298, -0.2007177323102951, 0.09845192730426788, 0.09493474662303925, 0.02445129305124283, 0.12864062190055847, 0.09290879219770432, -0.03306574374437332, -0.1035144180059433, 0.06655454635620117, -0.06535950303077698, 0.04330843314528465, -0.04226404428482056, 0.06786683201789856, -0.01270486880093813, -0.10893802344799042, 0.06469428539276123, 0.01096692681312561, 0.014121686108410358, -0.05614650249481201, 0.00855683907866478, -0.14082325994968414, 0.10572782158851624, 0.044292349368333817, 0.06485670804977417, -0.09829212725162506, -0.03783636912703514, -0.011875770054757595, 0.05909181386232376, -0.011104772798717022, -0.07409495860338211, -0.09745681285858154, -0.009533234871923923, 0.002077097073197365, 0.07160049676895142, 0.12457999587059021, -0.1179540604352951, -0.04891239106655121, 0.12667137384414673, -0.08803077787160873, -0.07377530634403229, 0.03719160705804825, -0.2492411732673645, -0.007075084839016199, -0.013849131762981415, -0.10746859014034271, 0.0120347049087286, -0.07201540470123291, -0.027430236339569092, -0.006232795305550098, 0.03163592517375946, -0.140333890914917, -0.11252415180206299, 0.018461311236023903, -0.008146354928612709, -0.04247133433818817, 0.16449551284313202, -0.313357412815094, 0.053076110780239105, 0.05364483222365379], "changes": {"1wk": -14.275717055974676, "1mo": -11.406578857887911}}, {"text": "Evolus Reports Third Quarter 2024 Results Business Wire Thu, Nov 7, 2024, 12:05 AM 17 min read In This Article: EOLS -7.09% Total Net Revenue of $61.1 Million for Q3 2024, Up 22% from Q3 2023; Year-To-Date Growth of 33% Received Approval for Estyme \u00ae Injectable Hyaluronic Acid (HA) Gels in the European Union; Experience Program to Launch Immediately with Full Launch Expected in the Second Half of 2025 Premarket Approval (PMA) Application for Evolysse\u2122 Form and Evolysse\u2122 Smooth Injectable HA Gels Currently Under Review by the U.S. Food and Drug Administration (FDA) with Approval and Launch Expected by September 2025 Narrows Full-Year 2024 Net Revenue Guidance to $260 Million to $266 Million, Representing Year-Over-Year Growth of 29% to 32% Reaffirms Non-GAAP Profitability 1 in Q4 2024 and Full Year 2025 Remains on Track to Achieve Projected Total Net Revenue Goal of At Least $700 Million and Operating Margin of At Least 20% by 2028 NEWPORT BEACH, Calif., November 06, 2024 --( BUSINESS WIRE )-- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported financial results for the third quarter ended September 30, 2024, and provided a business update. \"Our third quarter results underscore the momentum we\u2019ve been building throughout the year,\" said David Moatazedi, President and Chief Executive Officer. \"We continue to deliver growth at multiples above the market, validating our performance beauty approach in the medical aesthetics industry. Jeuveau \u00ae , our flagship brand, resonates with a younger generation of consumers, as demonstrated by the recent achievement of over one million total consumers enrolled in our loyalty program. Our deep customer engagement and cash-pay focus differentiate us in the category and pave the way for the upcoming launch of Evolysse\u2122.\" \"Last week, we received approval for Estyme \u00ae in the European Union, putting Evolus in a unique position as one of only five companies in Europe with both a neurotoxin and injectable HA gel line. We have initiated our early experience program and expect a full launch in the second half of 2025. Key learnings from Europe will inform the U.S. launch of our first two Evolysse\u2122 injectable HA gels, Form and Smooth, which we anticipate will take place by September 2025, followed by Sculpt in 2026, and Lips in 2027. These launches will enable us to expand our market presence while benefiting from our existing infrastructure.\" Third Quarter 2024 Highlights and Recent Developments The company\u2019s key performance indicators demonstrated continued strong momentum during the third quarter. Evolus added over 600 new customer accounts in the quarter, bringing the total number of customers purchasing since launch to nearly 14,500. The reorder rate among customers was approximately 70% 2 . Members in the Evolus Rewards\u2122 consumer loyalty program grew by over 72,000 to approximately 975,000 3 . As of November 2024, the Evolus Rewards\u2122 consumer loyalty program has surpassed 1 million enrolled consumers. Total Evolus Rewards\u2122 redemptions for the quarter hit an all-time high of over 190,000 3 with existing patients receiving repeat treatments at the rate of approximately 65%, which demonstrates growing consumer adoption and utilization. As of November 2024, total Evolus Rewards\u2122 redemptions have surpassed 2 million reflective of sustained brand loyalty. Launched Club Evolus\u2122, the first subscription-based program by a neurotoxin manufacturer, in early November. Evolus received approval for its Estyme \u00ae injectable hyaluronic acid (HA) gels in the European Union, with an experience program to launch immediately, and full launch expected in the second half of 2025. Story Continues Third Quarter 2024 Financial Results Total net revenues for the third quarter of 2024 increased 22% to $61.1 million from $50.0 million in the third quarter of 2023 driven primarily by higher volumes of Jeuveau \u00ae . Gross profit margin and adjusted gross profit margin were 68.9% and 70.2%, respectively. Adjusted gross profit margin, which excludes amortization of intangible assets, aligns with company guidance for the full year, as noted below. Operating expenses for the third quarter of 2024 were $76.6 million, compared to $74.6 million in the second quarter of 2024. Non-GAAP operating expenses for the third quarter of 2024 were $49.6 million, compared to $46.7 million in the second quarter of 2024. Non-GAAP operating expenses exclude product cost of sales, stock-based compensation expense, revaluation of the contingent royalty obligation, and depreciation and amortization. Loss from operations for the third quarter of 2024 was $15.5 million, compared to $7.7 million in the second quarter of 2024. Non-GAAP loss from operations in the third quarter of 2024 was $6.7 million compared to a $1.1 million income from operations in the second quarter of 2024. The decline in operating income quarter over quarter was primarily driven by typical seasonality of revenue. Non-GAAP income (loss) from operations excludes stock-based compensation expense, revaluation of the contingent royalty obligation, and depreciation and amortization. Cash and cash equivalents at September 30, 2024 were $85.0 million compared to $93.7 million at June 30, 2024, representing a single-digit cash use for the quarter and continued progress toward cash generation. Outlook Evolus narrows its full year total net revenue guidance to $260 million to $266 million, representing year-over-year growth of 29% to 32% from 2023 results and well above the estimated growth rate of the aesthetic neurotoxin market. The company continues to expect its adjusted gross profit margin for the full year 2024 to be between 68% and 71%. Evolus continues to expect its full-year non-GAAP operating expenses to be between $185 million and $190 million. The company continues to expect to achieve positive non-GAAP operating income on a consolidated basis for the fourth quarter of 2024 and for the full year 2025. PMA application for Evolysse \u2122 Form and Evolysse \u2122 Smooth injectable HA gels currently under review by the U.S. FDA with approval and launch expected by September 2025. The company projects total net revenue of at least $700 million by 2028, a compound annual growth rate of 28% from 2023, based on the combination of its existing aesthetic neurotoxin business and anticipated launch of the novel line of injectable hyaluronic acid gels beginning in 2025. Evolus continues to expect to expand operating margins by leveraging its highly synergistic, existing infrastructure, with a target of at least 20% by 2028. Conference Call Information Management will host a conference call and live webcast to discuss Evolus\u2019 financial results today at 4:30 p.m. ET. To participate in the conference call, dial (877) 407-6184 (U.S.) or (201) 389-0877 (international) or connect to the live webcast via the link on the Investor Relations page of our website at www.evolus.com . Following the completion of the call, an audio replay can be accessed for 48 hours by dialing (877) 660-6853 (U.S.) or (201) 612-7415 (international) and using conference number 13749542. An archived webcast, which will remain available for 30 days, can also be accessed on the Investor Relations page of our website at www.evolus.com . About Evolus, Inc. Evolus (NASDAQ: EOLS) is a global performance beauty company evolving the aesthetic neurotoxin market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global, multi-product aesthetics company based on our flagship product, Jeuveau \u00ae (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure\u2122 technology. Evolus is expanding its product portfolio having entered into a definitive agreement to be the exclusive U.S. distributor of Evolysse \u2122 , and the exclusive distributor in Europe of Estyme \u00ae , a line of unique injectable hyaluronic acid (HA) gels. These injectable HA gels are currently in the late stages of the regulatory approval process, with plans, upon approval, for a launch starting in 2025. Visit us at www.evolus.com , and follow us on LinkedIn , X , Instagram or Facebook . 1 \"Profitability\" is not a measure presented in accordance with GAAP. Within this press release, \"profitability\" is defined as achieving positive non-GAAP operating income. See \"Use of Non-GAAP Financial Measures\" below for more information on the company\u2019s use and definitions of non-GAAP measures. 2 Represents cumulative statistics from the launch of Jeuveau \u00ae in May 2019 through September 30, 2024. 3 Represents cumulative statistics from the launch of Evolus Rewards \u2122 in May 2020 through September 30, 2024. Use of Non-GAAP Financial Measures Evolus\u2019 financial results are prepared in accordance with accounting principles generally accepted in the United States of America (\"GAAP\"). This press release and the reconciliation tables included in the financial schedules below include adjusted gross profit, adjusted gross profit margin, non-GAAP operating expenses and non-GAAP income (loss) from operations. Adjusted gross profit is calculated as gross profit excluding amortization of an intangible asset. Adjusted gross profit margin is defined as adjusted gross profit as a percentage of total net revenues. Non-GAAP operating expenses and non-GAAP income (loss) from operations exclude (i) product cost of sales, in the case of non-GAAP operating expenses only, (ii) the revaluation of contingent royalty obligations, (iii) stock-based compensation expense, and (iv) depreciation and amortization. Management believes that adjusted gross profit and adjusted gross profit margin are important measures for investors because management uses adjusted gross profit margin as a key performance indicator to evaluate the profitability of sales without giving effect to costs that are not core to our cost of sales, such as the amortization of an intangible asset. Management believes that non-GAAP operating expenses and non-GAAP income (loss) from operations are useful in helping to identify the company\u2019s core operating performance and enables management to consistently analyze the period-to-period financial performance of the core business operations. Management also believes that non-GAAP operating expenses and non-GAAP income (loss) from operations will enable investors to assess the company in the same way that management has historically assessed the company\u2019s operating expenses against comparable companies with conventional accounting methodologies. The company\u2019s definitions of adjusted gross profit, adjusted gross profit margin, non-GAAP operating expenses and non-GAAP income (loss) from operations have limitations as analytical tools and may differ from other companies reporting similarly named measures. Non-GAAP measures should not be considered measures of financial performance under GAAP, and the items excluded from such non-GAAP measures should not be considered in isolation or as alternatives to financial statement data presented in the financial statements as an indicator of financial performance or liquidity. Non-GAAP measures should be considered in addition to results prepared in accordance with GAAP but should not be considered a substitute for or superior to GAAP results. For a reconciliation of our historical adjusted gross profit, adjusted gross profit margin, non-GAAP operating expenses and non-GAAP income (loss) from operations presented herein to gross profit, gross profit margin, GAAP operating expenses and GAAP loss from operations, the most directly comparable GAAP financial measures, please see \"Reconciliation of Gross Profit Margin to Adjusted Gross Profit Margin,\" \"Reconciliation of GAAP Operating Expenses to Non-GAAP Operating Expenses\" and \"Reconciliation of GAAP (Loss) from Operations to Non-GAAP Income (Loss) from Operations\" in the financial schedules below. In addition, this press release includes information regarding the company\u2019s expected adjusted gross profit margin and non-GAAP operating expenses for full year 2024 and the company\u2019s expected non-GAAP operating income (loss) for the fourth quarter of 2024 and full year 2025. Evolus has not provided a reconciliation of such forward-looking non-GAAP adjusted gross profit margin, non-GAAP operating expenses or non-GAAP operating (loss) because a reconciliation of such measures to forward-looking GAAP gross profit margin, GAAP operating expenses and GAAP loss from operations, respectively, the most directly comparable GAAP financial measures, is not available without unreasonable efforts. This is due to the inherent difficulty of forecasting the timing or amount of various reconciling items that would impact the forward-looking outlook for these non-GAAP financial measures that have not yet occurred and/or cannot be reasonably predicted. Such unavailable information could have a significant impact on Evolus\u2019 GAAP financial results. Forward-Looking Statements This press release contains forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties, including statements about future events, our business, financial condition, results of operations and prospects, our industry and the regulatory environment in which we operate. Any statements contained herein that are not statements of historical or current facts are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as \"anticipate,\" \"believe,\" \"could,\" \"estimate,\" \"expect,\" \"intend,\" \"may,\" \"plan,\" \"potential,\" \"predict,\" \"project,\" \"should,\" \"will,\" \"would\" or the negative of those terms, or other comparable terms intended to identify statements about the future. The company\u2019s forward-looking statements include, but are not limited to, statements related to anticipated product launches; market conditions and consumer demand; timing of regulatory submissions and approvals; expansions into new markets; the company\u2019s long-term revenue outlook and its financial outlook for 2024 and, in the case of non-GAAP operating income, 2025; and the company\u2019s cash position and expectations for reaching profitability 1 and funding the company\u2019s operations. The forward-looking statements included herein are based on our current expectations, assumptions, estimates and projections, which we believe to be reasonable, and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the forward-looking statements. These risks and uncertainties, all of which are difficult or impossible to predict accurately and many of which are beyond our control, include, but are not limited to uncertainties associated with our ability to comply with the terms and conditions in the Medytox Settlement Agreements, our ability to fund our future operations or obtain financing to fund our operations, unfavorable global economic conditions and the impact on consumer discretionary spending, uncertainties related to customer and consumer adoption of Jeuveau \u00ae and Evolysse \u2122 , the efficiency and operability of our digital platform, competition and market dynamics, our ability to successfully launch and commercialize our products in new markets, including the Evolysse \u2122 Hyaluronic Acid (HA) gels in the U.S., our ability to maintain regulatory approvals of Jeuveau \u00ae or obtain regulatory approvals for new product candidates or indications, our reliance on Symatese to achieve regulatory approval for the Evolysse \u2122 HA gel line in the U.S., and other risks described in our filings with the Securities and Exchange Commission, including in the section entitled \"Risk Factors\" in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, as filed with the Securities and Exchange Commission on July 31, 2024, and our Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 expected to be filed with the Securities and Exchange Commission on or about November 6, 2024. These filings can be accessed online at www.sec.gov . Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Except as required by law, we undertake no obligation to update or revise any forward-looking statements to reflect new information, changed circumstances or unanticipated events. If we do update or revise one or more of these statements, investors and others should not conclude that we will make additional updates or corrections. Jeuveau \u00ae and Nuceiva \u00ae , are registered trademarks and Evolysse \u2122 is a trademark of Evolus, Inc. Hi-Pure \u2122 is a trademark of Daewoong Pharmaceutical Co, Ltd. Estyme \u00ae is a trademark of Symatese Aesthetics S.A.S. Evolus, Inc. Consolidated Statements of Operations and Comprehensive Loss (Unaudited, in thousands, except loss per share data) Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Revenue: Product revenue, net $ 60,164 $ 49,323 $ 185,350 $ 139,050 Service revenue 921 696 1,977 2,036 Total net revenues 61,085 50,019 187,327 141,086 Operating expenses: Product cost of sales (excludes amortization of intangible assets) 18,223 15,431 55,367 42,289 Selling, general and administrative 52,506 43,328 147,781 121,886 Research and development 2,314 1,587 6,742 4,176 In-process research and development \u2014 \u2014 \u2014 4,441 Revaluation of contingent royalty obligation payable to Evolus Founders 2,428 1,802 5,611 5,132 Depreciation and amortization 1,087 1,311 3,923 3,760 Total operating expenses 76,558 63,459 219,424 181,684 Loss from operations (15,473 ) (13,440 ) (32,097 ) (40,598 ) Other income (expense): Interest income 928 306 2,474 569 Interest expense (4,764 ) (3,786 ) (14,162 ) (9,757 ) Other income (expense), net 273 21 380 2 Loss before income taxes: (19,036 ) (16,899 ) (43,405 ) (49,784 ) Income tax expense 134 24 224 70 Net loss $ (19,170 ) $ (16,923 ) $ (43,629 ) $ (49,854 ) Other comprehensive loss: Unrealized loss, net of tax (88 ) (138 ) (262 ) (269 ) Comprehensive loss $ (19,258 ) $ (17,061 ) $ (43,891 ) $ (50,123 ) Net loss per share, basic and diluted $ (0.30 ) $ (0.30 ) $ (0.71 ) $ (0.88 ) Weighted-average shares outstanding used to compute basic and diluted net loss per share 63,149 57,023 61,563 56,808 Evolus, Inc. Summary of Consolidated Balance Sheet Data (Unaudited, in thousands) September 30, 2024 December 31, 2023 Cash and cash equivalents $ 85,035 $ 62,838 Accounts receivable, net 44,642 30,529 Inventories 14,892 10,998 Prepaid expenses and other current assets 5,792 8,056 Total current assets 150,361 112,421 Noncurrent assets 79,247 76,577 Total assets $ 229,608 $ 188,998 Accounts payable and accrued expenses $ 48,785 $ 38,084 Other current liabilities 12,030 10,207 Total current liabilities 60,815 48,291 Term loan, net of discount and issuance costs 121,208 120,359 Other noncurrent liabilities 41,695 41,037 Total liabilities $ 223,718 $ 209,687 Total stockholders\u2019 equity (deficit) $ 5,890 $ (20,689 ) Evolus, Inc. Summary of Consolidated Cash Flows (Unaudited, in thousands) Nine Months Ended September 30, Three Months Ended September 30, 2024 2023 2024 Net cash (used in) provided by: Operating activities $ (22,807 ) $ (34,821 ) * $ (5,722 ) Investing activities (3,461 ) (1,266 ) (1,410 ) Financing activities 48,727 21,119 (1,416 ) Effect of exchange rates on cash (262 ) (269 ) (88 ) Change in cash and cash equivalents 22,197 (15,237 ) (8,636 ) Cash and cash equivalents, beginning of period 62,838 53,922 93,671 Cash and cash equivalents, end of period $ 85,035 $ 38,685 $ 85,035 *Includes a settlement payment of $5.0 million to Allergan/Medytox in the nine months ended September 30, 2023. Evolus, Inc. Reconciliation of Gross Profit Margin to Adjusted Gross Profit Margin (Unaudited, in thousands) Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Total net revenues $ 61,085 $ 50,019 $ 187,327 $ 141,086 Cost of sales: Product cost of sales (excludes amortization of intangible assets) 18,223 15,431 55,367 42,289 Amortization of distribution right intangible asset 763 738 2,290 2,216 Total cost of sales 18,986 16,169 57,657 44,505 Gross profit 42,099 33,850 129,670 96,581 Gross profit margin 68.9 % 67.7 % 69.2 % 68.5 % Add: Amortization of distribution right intangible asset 763 738 2,290 2,216 Adjusted gross profit $ 42,862 $ 34,588 $ 131,960 $ 98,797 Adjusted gross profit margin 70.2 % 69.1 % 70.4 % 70.0 % Evolus, Inc. Reconciliation of GAAP Operating Expenses to Non-GAAP Operating Expenses (Unaudited, in thousands) Three Months Ended September 30, Nine Months Ended September 30, Three Months Ended June 30, 2024 2023 2024 2023 2024 GAAP operating expense $ 76,558 $ 63,459 $ 219,424 $ 181,684 $ 74,611 Adjustments: Product cost of sales (excludes amortization of intangible assets) 18,223 15,431 55,367 42,289 19,077 Revaluation of contingent royalty obligation 2,428 1,802 5,611 5,132 1,605 Stock-based compensation: Included in selling, general and administrative 4,955 4,295 15,370 11,445 5,552 Included in research and development 265 301 713 616 232 Depreciation and amortization 1,087 1,311 3,923 3,760 1,427 Non-GAAP operating expense $ 49,600 $ 40,319 $ 138,440 $ 118,442 $ 46,718 Evolus, Inc. Reconciliation of GAAP (Loss) from Operations to Non-GAAP Income (Loss) from Operations (Unaudited, in thousands) Three Months Ended September 30, Nine Months Ended September 30, Three Months Ended June 30, 2024 2023 2024 2023 2024 GAAP (loss) from operations $ (15,473 ) $ (13,440 ) $ (32,097 ) $ (40,598 ) $ (7,702 ) Adjustments: Revaluation of contingent royalty obligation 2,428 1,802 5,611 5,132 1,605 Stock-based compensation: Included in selling, general and administrative 4,955 4,295 15,370 11,445 5,552 Included in research and development 265 301 713 616 232 Depreciation and amortization 1,087 1,311 3,923 3,760 1,427 Non-GAAP income (loss) from operations $ (6,738 ) $ (5,731 ) $ (6,480 ) $ (19,645 ) $ 1,114 View source version on businesswire.com: https://www.businesswire.com/news/home/20241106023548/en/ Contacts Investor Contact: Nareg Sagherian Vice President, Head of Global Investor Relations and Corporate Communications Tel: 248-202-9267 Email: ir@evolus.com Media Contact : Email: media@evolus.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "EOLS", "date": "2024-11-07T00:05:00", "sentiment": {"score": 0.9192469697445631, "confidence": 0.9284148812294006, "probabilities": {"positive": 0.9284148812294006, "negative": 0.009167911484837532, "neutral": 0.06241720914840698}}, "embedding": [-0.08644597232341766, -0.02473529800772667, -0.04535990580916405, -0.024652665480971336, -0.06724609434604645, 0.010370273143053055, -0.03573416918516159, 0.17442578077316284, 0.052189894020557404, -0.047884561121463776, 0.025473717600107193, 0.05967041105031967, 0.01824311353266239, -0.026632994413375854, 0.01099761575460434, -0.006184542551636696, 0.12638655304908752, -0.0774594321846962, -0.030910788103938103, -0.012382058426737785, 0.09948816895484924, -0.04831035062670708, -0.01689939945936203, -0.05069485306739807, -0.03213077038526535, -0.02881871908903122, -0.07323608547449112, -0.014355352148413658, -0.14016269147396088, -0.1392335593700409, 0.043324701488018036, 0.03769325092434883, 0.03663117438554764, -0.20211948454380035, 0.06691206246614456, -0.007815459743142128, -0.16560712456703186, -0.1230483278632164, -0.006123071536421776, -0.033134520053863525, -8.9684734120965e-05, -0.1574159562587738, -0.2832489311695099, 0.03608044981956482, 0.019941706210374832, -0.15201552212238312, 0.053004175424575806, 0.009412821382284164, -0.026989471167325974, 0.08304472267627716, -0.13329657912254333, -0.15301063656806946, 0.08439565449953079, -0.09246985614299774, -0.11462123692035675, 0.005811119452118874, -0.1791844516992569, -0.028685081750154495, -0.005559245124459267, 0.009853861294686794, -0.020988941192626953, 0.037373535335063934, -0.0073542725294828415, 0.05012745410203934, 0.030077064409852028, -0.036333613097667694, 0.03065180405974388, -0.03883396461606026, -0.07785944640636444, -0.057726554572582245, 0.08668127655982971, -0.1030215471982956, -0.02491612359881401, 0.03237127140164375, 0.05553975701332092, 0.21131348609924316, 0.1437782645225525, 0.07085786759853363, 0.0886620283126831, -0.13486960530281067, 0.09920145571231842, -0.026014696806669235, -0.032176241278648376, 0.005961155518889427, -0.04610782116651535, 0.004749074578285217, 0.01886901818215847, 0.030383775010704994, 0.005620509386062622, 0.10502730309963226, 0.11979643255472183, -0.06966196000576019, -0.02114388346672058, 0.019471440464258194, 0.035997625440359116, -0.007822297513484955, -0.102615587413311, -0.08798807859420776, 0.0070508262142539024, 0.06082882732152939, -0.03679506108164787, 0.14085642993450165, -0.01947968825697899, -0.07514685392379761, -0.050863802433013916, -0.06181156635284424, 0.0031090807169675827, -0.014292391017079353, 0.10635595768690109, -0.01251972559839487, -0.10318604856729507, -0.06123688817024231, -0.04520825296640396, -0.0639662891626358, -0.05738481879234314, 0.15073665976524353, -0.010405540466308594, 0.08037346601486206, 0.24172234535217285, -0.06603758037090302, 0.08431284874677658, 0.052833300083875656, 0.046456508338451385, -0.047590844333171844, 0.01064272876828909, 0.01884344592690468, -0.034843556582927704, 1.339449364139103e-32, -0.1150805652141571, 0.051343582570552826, 0.03315228968858719, 0.009294005110859871, -0.07814259827136993, 0.06298580765724182, -0.007168585434556007, 0.04201653599739075, -0.10457789897918701, -0.014225692488253117, -0.20944824814796448, 0.0632486492395401, -0.020315304398536682, 0.13618314266204834, 0.02285216562449932, -0.15970022976398468, -0.0860811248421669, 0.06422974169254303, 0.045296452939510345, 0.019152749329805374, 0.002058227313682437, -0.08090443909168243, 0.03900299221277237, 0.09840553998947144, -0.08989005535840988, 0.13033029437065125, 0.01982431299984455, 0.006253491155803204, 0.033034421503543854, 0.07168214023113251, -0.01586362160742283, 0.05032160505652428, 0.04701437056064606, -0.10984532535076141, -0.16814342141151428, -0.002865731716156006, -0.07710884511470795, -0.1419985294342041, 0.03436822444200516, -0.04342005401849747, -0.035354796797037125, 0.10658498108386993, -0.04312225803732872, -0.03429296612739563, -0.030834514647722244, 0.013693558052182198, -0.0058259861543774605, -0.012231159955263138, 0.006319141946732998, -0.025155900046229362, -0.09043847024440765, 0.04812812805175781, 0.07649737596511841, -0.010208307765424252, -0.010610516183078289, 0.022693883627653122, -0.0712355524301529, 0.017752630636096, 0.07240786403417587, 0.031239598989486694, -0.0502687431871891, 0.20103493332862854, -0.06695833057165146, -0.020926639437675476, -0.0761418491601944, 0.1912064552307129, 0.03928258642554283, -0.0526021271944046, -0.08654971420764923, 0.045746803283691406, 0.03822409361600876, -0.0070033324882388115, 0.14684709906578064, -0.09422770142555237, 0.1188979297876358, -0.02812359482049942, -0.002523161005228758, 0.07691563665866852, 0.10390734672546387, -0.049518097192049026, -0.04527822136878967, 0.05716978758573532, -0.026627346873283386, 0.03030340187251568, 0.15042707324028015, -0.004315701778978109, 0.029525330290198326, 0.04623524472117424, 0.030292417854070663, 0.08173178136348724, 0.09752976894378662, -0.025774072855710983, 0.034145839512348175, 0.21716070175170898, -0.03490824997425079, -1.2433077383004622e-32, -0.05951381474733353, 0.005001606419682503, -0.029572563245892525, 0.01911664567887783, 0.08434545248746872, 0.005669284611940384, 0.061168085783720016, 0.08765055984258652, 0.00910913571715355, -0.07574190199375153, 0.050073254853487015, 0.06642800569534302, -0.008155575022101402, -0.01764417625963688, -0.04034266248345375, 0.04757167398929596, 0.004238253924995661, -0.13405127823352814, 0.015929777175188065, 0.04009050130844116, 0.027930431067943573, 0.20200319588184357, -0.06688244640827179, 0.08828449994325638, 0.06986159831285477, 0.095007985830307, 0.05848629027605057, 0.04884476214647293, -0.024669332429766655, -0.09282292425632477, -0.08853502571582794, -0.01995830610394478, -0.1633450835943222, 0.037271786481142044, -0.008913548663258553, 0.03623594716191292, 0.04151846095919609, -0.06240532547235489, 0.028822902590036392, -0.029706325381994247, 0.033634450286626816, -0.03196940943598747, -0.07182233035564423, 0.019649751484394073, 0.05215442553162575, 0.06182433292269707, 0.036013051867485046, -0.08820649981498718, 0.12603431940078735, 0.08130057156085968, -0.013126242905855179, 0.1306048184633255, -0.10023532062768936, 0.04521021991968155, -0.06814716756343842, -0.032586514949798584, -0.0018848669715225697, -0.012060979381203651, -0.1407146006822586, 0.03907378762960434, -0.003058517351746559, 0.11782878637313843, 0.10612180083990097, -0.02271895855665207, 0.08836632966995239, 0.03354056552052498, 0.0802769735455513, -0.013408621773123741, 0.0059595671482384205, -0.15816274285316467, 0.05926220118999481, 0.006426092702895403, -0.07941088080406189, -0.11803142726421356, 0.0033346833661198616, 0.03993257135152817, 0.01715022698044777, -0.1595119833946228, -0.08465400338172913, -0.1333397924900055, -0.06866828352212906, 0.025467129424214363, -0.014576902613043785, 0.014366021379828453, 0.08493182808160782, 0.057547762989997864, -0.04011715203523636, -0.03706275299191475, 0.01670810580253601, 0.09381560236215591, -0.06141381710767746, 0.00010848697274923325, -0.04650846868753433, 0.14305813610553741, 0.1616096794605255, -1.0081959089802695e-07, 0.1318683922290802, 0.01178780011832714, 0.07538861036300659, -0.03560204803943634, 0.14900614321231842, -0.1576092541217804, -0.037868931889534, 0.07723622024059296, -0.0374474935233593, 0.07101523131132126, 0.039830051362514496, 0.16697898507118225, -0.1009257361292839, 0.06787072867155075, -0.046072665601968765, 0.06590884923934937, -0.012272164225578308, 0.1592121422290802, -0.0962788462638855, -0.11326633393764496, -0.028003109619021416, 0.08073912560939789, 0.03955338895320892, -0.13521595299243927, 0.025253109633922577, -0.1643592268228531, -0.01616431586444378, -0.0582357719540596, -0.034801989793777466, -0.08795799314975739, 0.09571398049592972, 0.023496152833104134, 0.04993429780006409, -0.020739583298563957, -0.07338795065879822, -0.14378297328948975, 0.010381612926721573, 0.0825936496257782, -0.022426534444093704, 0.037621915340423584, -0.04319208115339279, -0.0893474817276001, 0.003969187848269939, -0.009184038266539574, -0.06868624687194824, -0.0445394292473793, -0.12919306755065918, 0.01972544938325882, 0.009532521478831768, 0.045667022466659546, -0.06792840361595154, -0.04334490746259689, -0.02109541743993759, -0.0882638692855835, 0.05396100878715515, -0.07297231256961823, -0.04204120859503746, -0.026530390605330467, 0.008283336646854877, 0.003569573862478137, 0.11297263950109482, -0.2206730842590332, 0.15752363204956055, 0.06188841909170151], "changes": {"1wk": -27.12670797629169, "1mo": -24.687684416280383}}]